0001683168-23-001819.txt : 20230328 0001683168-23-001819.hdr.sgml : 20230328 20230328083050 ACCESSION NUMBER: 0001683168-23-001819 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 20 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AUDDIA INC. CENTRAL INDEX KEY: 0001554818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 454257218 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-270813 FILM NUMBER: 23766300 BUSINESS ADDRESS: STREET 1: 2100 CENTRAL AVENUE STREET 2: SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-219-9771 MAIL ADDRESS: STREET 1: 2100 CENTRAL AVENUE STREET 2: SUITE 200 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Clip Interactive, LLC DATE OF NAME CHANGE: 20120724 S-1/A 1 auddia_s1-a1.htm AMENDMENT NO. 1 TO FORM S-1
0001554818 true various edits 0001554818 2023-03-23 2023-03-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

Table of Contents

 

As filed with the Securities and Exchange Commission on March 28, 2023

 

Registration No. 333-270813

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Amendment No. 1

to

 

FORM S-1/A

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

Auddia Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   7371   45-4257218

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

2100 Central Ave., Suite 200

Boulder, Colorado 80301

(303) 219-9771

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Michael Lawless

Chief Executive Officer

Auddia Inc.

2100 Central Ave., Suite 200

Boulder, Colorado 80301

(303) 219-9771

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

    Barry I. Grossman, Esq.
James H. Carroll, Esq.   Sarah Williams, Esq.
Carroll Legal LLC   Ellenoff Grossman & Schole LLP
1449 Wynkoop Street, Suite 507   1345 Avenue of the Americas, 11th Floor,
Denver, CO  80202   New York, NY 10105
(303) 888-4859   (212) 370-1300

 

 

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box.  ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer     Accelerated filer  
Non-accelerated filer     Smaller reporting company  
        Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.  

 

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

   

 

 

The information contained in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

Preliminary Prospectus,

Subject to Completion, dated March 28, 2023

 

AUDDIA INC.

 

6,819,732 UNITS CONSISTING OF

ONE SHARE OF COMMON STOCK,

OR ONE PRE-FUNDED WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK, AND

ONE WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK

 

We are offering up to 6,819,732 units, each consisting of one share of our common stock, par value $0.001 per share, and one warrant to purchase one share of common stock (“Common Warrants”), in a firm commitment underwritten public offering at an assumed offering price of $0.8798 per unit, which is equal to the closing price of our common stock on the Nasdaq Capital Market on March 24, 2023, for gross proceeds of approximately $6.0 million. Each Common Warrant will have an exercise price of $[·] per share of common stock (equal to 100% of the public offering price of each unit sold in this offering), will be exercisable immediately, and will expire five years from the date of issuance.

 

We are also offering to each purchaser of units that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of our outstanding common stock immediately following the consummation of this offering the opportunity to purchase units consisting of one pre-funded warrant (in lieu of one share of common stock) (Pre-Funded Warrant”) and one Common Warrant. A holder of pre-funded warrants will not have the right to exercise any portion of its pre-funded warrants if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the election of the holder, such limit may be increased to up to 9.99%) of the number of shares of common stock outstanding immediately after giving effect to such exercise. Each pre-funded warrant will be exercisable for one share of common stock. The purchase price of each unit including a Pre-Funded Warrant will be equal to the price per unit including one share of common stock, minus $0.0001, and the remaining exercise price of each Pre-Funded Warrant will equal $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. For each unit including a Pre-Funded Warrant we sell (without regard to any limitation on exercise set forth therein), the number of units including a share of common stock we are offering will be decreased on a one-for-one basis.

 

The shares of our common stock and Pre-Funded Warrants, if any, and the accompanying Common Warrants can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance. We are also registering the shares of common stock issuable from time to time upon exercise of the Common Warrants and Pre-Funded Warrants included in the units offered hereby.

 

Our common stock is traded on the Nasdaq Capital Market under the symbol “AUUD.” On March 22, 2023, the closing price for our common stock, as reported on the Nasdaq Capital Market, was $0.96 per share. The public offering price per unit will be determined at the time of pricing and may be at a discount to the then current market price. The recent market price used throughout this prospectus may not be indicative of the final offering price. The final public offering price will be determined through negotiation between us and investors based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering.

 

There is no established public trading market for the Pre-Funded Warrants or Common Warrants, and we do not expect a market to develop. Without an active trading market, the liquidity of the Pre-Funded Warrants and Common Warrants will be limited. In addition, we do not intend to list the Pre-Funded Warrants or the Common Warrants on the Nasdaq Capital Market, any other national securities exchange or any other trading system.

 

Our Series A Warrants offered in connection with our February 2021 initial public offering are quoted on the Nasdaq Capital Market under the symbol “AUUDW.” The last reported sale price of our Series A Warrants on the Nasdaq Capital Market on March 22, 2023 was $0.218 per Series A Warrant.

 

 

   

 

 

We are an “emerging growth company” and a “smaller reporting company” as defined under the federal securities laws and, as such, have elected to be subject to reduced public company reporting requirements.

 

    Per Unit(1)     Total  
Public offering price   $       $    
Underwriting discounts and commissions (2) (3)   $       $    
Proceeds, before expenses, to us   $       $    

 

(1) Units consist of one share of common stock, or one Pre-Funded Warrant to purchase one share of common stock, and one Common Warrant to purchase one share of common stock.

(2) We have granted the underwriters an option to purchase an additional [·] shares of common stock and/or Common Warrants to purchase [·] additional shares of common stock from us (being up to 15% of the shares of common stock (including shares underlying Pre-Funded Warrants) and/or up to 15% of the Common Warrants sold in this offering), in any combination thereof, at the public offering price per share and public offering price per Common Warrant, respectively, less the underwriting discounts and commissions, for 45 days from the date of this prospectus.

(3) The underwriting discount shall equal 7.0% of the gross proceeds of the securities sold by us in this offering. The underwriter will receive compensation in addition to the underwriting discount described above. See “Underwriting” for a description of compensation payable to the underwriter.

 

We anticipate that delivery of the securities against payment will be made on or about [·], 2023.

 

Investing in our securities involves a high degree of risk. Before buying any shares, you should carefully read the discussion of material risks of investing in our securities in “Risk Factors” beginning on page 9 of this prospectus.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed on the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

 

Ladenburg Thalmann Maxim Group

 

 

The date of this prospectus is ___________, 2023

 

 

 

 

   

 

 

TABLE OF CONTENTS

 

  Page
Prospectus Summary 1
Information Regarding Forward-Looking Statements 6
The Offering 7
Risk Factors 9
Market and Industry Data 10
Use of Proceeds 11
Dividend Policy 11
Capitalization 11
Dilution 13
Description of Capital Stock 14
Description of Securities We Are Offering 19
Shares Eligible for Future Sale 21
Underwriting 22
Legal Matters 25
Experts 25
Where You Can Find More Information 26
Incorporation of Certain Information by Reference 26

 

 

 

 

 

 

 

 

 

 

 i 

 

 

Neither we nor the underwriters have authorized anyone to provide any information or to make any representations other than those contained in or incorporated by reference in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares of common stock offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in or incorporated by reference in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.

 

To the extent there is a conflict between the information contained in this prospectus, on the one hand, and the information contained in any document incorporated by reference filed with the Securities and Exchange Commission, or the SEC, before the date of this prospectus, on the other hand, you should rely on the information in this prospectus. If any statement in a document incorporated by reference is inconsistent with a statement in another document incorporated by reference having a later date, the statement in the document having the late date modifies or supersedes the earlier statement.

 

No action is being taken in any jurisdiction outside the United States to permit a public offering of our common stock or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction.

 

Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity and market share, is based on information from our own management estimates and research, as well as from industry and general publications and research, surveys and studies conducted by third-parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge, which we believe to be reasonable. Our management estimates have not been verified by any independent source, and we have not independently verified any third-party information. In addition, assumptions and estimates of our and our industry’s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk Factors.” These and other factors could cause our future performance to differ materially from our assumptions and estimates. See “Risk Factors” and “Information Regarding Forward-Looking Statements.”

 

We further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.

 

We may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the sections of this prospectus entitled “Where You Can Find More Information.”

 

 

 

 ii 

 

 

PROSPECTUS SUMMARY

 

The following summary highlights information contained elsewhere in this prospectus and in documents incorporated by reference. This summary is not complete and may not contain all the information you should consider before investing in our securities. You should read this entire prospectus and the documents incorporated by reference in this prospectus carefully, especially the risks of investing in our securities discussed under the heading “Risk Factors,” and our financial statements and related notes incorporated by reference in this prospectus before making an investment decision. Except as otherwise indicated herein or as the context otherwise requires, references in this prospectus and the documents incorporated by reference in this prospectus to “Auddia”, “the Company,” “we,” “us” and “our” refer to Auddia Inc. This prospectus includes forward-looking statements that involve risks and uncertainties. See “Information Regarding Forward-Looking Statements.”

 

This prospectus includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this prospectus are the property of their respective owners.

 

Except as otherwise noted, all information in this prospectus reflects and assumes (i) no sale of Pre-Funded Warrants in this offering, which, if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no exercise of the Common Warrants issued in this offering.

 

Overview

 

Auddia is a technology company headquartered in Boulder, CO that is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia is leveraging these technologies within its industry-first audio Superapp, faidr (previously known as the Auddia App).

 

faidr gives consumers the opportunity to listen to any AM/FM radio station with no commercials while personalizing the listening experience through skips and the insertion of on-demand content, including popular and new music, news, and weather. The faidr app represents the first-time consumers can combine the local content uniquely provided by AM/FM radio with commercial-free and personalized listening many consumers demand from digital-media consumption. In addition to commercial-free AM/FM, faidr includes podcasts and exclusive content, branded faidrRadio, which includes new artist discovery, curated music stations, and Music Casts. Music Casts are unique to faidr. Hosts and DJs can combine on-demand talk segments with dynamic music streaming, which allows users to hear podcasts with full music track plays embedded in the episodes.

 

Auddia has also developed a podcasting platform that provides a unique suite of tools that helps Podcasters create additional digital content for their podcast episodes as well as plan their episodes, build their brand, and monetize their content with new content distribution channels. This podcast platform also gives users the ability to go deeper into the stories through supplemental, digital content, and eventually comment and contribute their own content to episode feeds.

 

Both of Auddia’s offerings address large and rapidly growing audiences.

 

The Company has developed its AI platform on top of Google’s TensorFlow open-source library that is being “taught” to know the difference between all types of audio content on the radio. For instance, the platform recognizes the difference between a commercial and a song and is learning the differences between all other content to include weather reports, traffic, news, sports, DJ conversation, etc. Not only does the technology learn the differences between the various types of audio segments, but it also identifies the beginning and end of each piece of content.

 

The Company is leveraging this technology platform within its premium AM/FM radio listening experience through the faidr App. The faidr App can be downloaded by consumers who will pay a subscription fee in order to listen to any streaming AM/FM radio station without commercials, podcasts and the faidrRadio exclusive content offerings. Advanced features will allow consumers to skip any content heard on the station, request audio content on-demand, and program an audio routine. We believe the faidr App represents a significant differentiated audio streaming product, or Superapp, to have come to market since the emergence of popular streaming music apps such as Pandora, Spotify, Apple Music, Amazon Music, etc.   We believe that the most significant point of differentiation is that in addition to ad-free AM/FM streaming, the faidr App will deliver non-music content that includes local sports, news, weather, traffic and the discovery of new music alongside exclusive programming and podcasts. No other radio streaming app available today, including category leaders like TuneIn, iHeart, and Audacy, can compete with faidr’s full product offerings.

 

 

 1 

 

 

The Company commissioned two separate surveys to establish subscription pricing in accordance with an industry standard pricing analysis. Results of both surveys, which included nearly 3,000 responses, suggested $12/month as the optimal price to maximize revenue and $7.99 to maximize market share and indicated that 29% of respondents were at least likely to subscribe to the product. The majority of respondents who self-identified as being listeners to paid services such as SiriusXM and streaming radio indicated a likely intent to purchase. We believe this implies a preference for the local content inherent in AM/FM broadcasting.

 

The Company launched all major U.S. radio stations on its faidr App on February 15, 2022.

 

The Company has also developed its podcasting platform, which leverages technologies and proven product concepts to differentiate its podcasts offering from other competitors in the radio streaming product category.

 

With podcasting growing and predicted to grow at a rapid rate, the Auddia podcast platform was conceptualized to fill a void in the emerging audio media space. The platform aims to be the preferred podcasting solution for podcasters by enabling them to deliver digital content feeds that match the audio of their podcast episodes, and by enabling podcasters to make additional revenue from new digital advertising channels; subscription channels; on-demand fees for exclusive content; and through direct donations from their listeners. Today, podcasters do not have a preference as to where their listeners access their episodes, as virtually all listening options (mobile apps and web players) deliver only their podcast audio. By creating a platform on which they can make net new and higher margin revenue, we believe that podcasters will promote faidr to their listeners, thus creating a powerful, organic marketing dynamic.

 

One innovative and proprietary part of the podcast platform is the availability of tools to create and distribute an interactive digital feed which supplements podcast episode audio with additional digital. These content feeds allow podcasters to tell deeper stories to their listeners while giving podcasters access to digital revenue for the first time. Podcasters will be able to build these interactive feeds using The Podcast Hub, a content management system that also serves as a tool to plan and manage podcast episodes. The digital feed activates a new digital ad channel that turns every audio ad into a direct-response, relevant-to-the-story, digital ad, increasing the effectiveness and value of their established audio ad model. The feed also presents a richer listening experience, as any element of a podcast episode can be supplemented with images, videos, text and web links. This feed will appear fully synchronized in the faidr mobile App, and it also can be hosted and accessed independently (e.g., through any browser), making the content feed universally distributable.

 

As the Company continues to enhance the functionality and features of faidr, over time users will be able to comment, and podcasters will be able to grant some users publishing rights to add content directly into the feed on their behalf. This will create another first for podcasting, a dialog between creator and fan, synchronized to the episode content.

 

The podcast capabilities within faidr will also introduce a unique and industry first multi-channel, highly flexible set of revenue channels that podcasters can activate in combination to allow listeners to choose how they want to consume and pay for content. “Flex Revenue” allows podcasters to continue to run their standard audio ad model and complement those ads with direct response enabled digital ads in each episode content feed, increasing the value of advertising on any podcast. “Flex Revenue” will also activate subscriptions, on-demand fees for content (e.g., listen without audio ads for a micro payment fee) and direct donations from listeners. Using these channels in combination, podcasters can maximize revenue generation and exercise higher margin monetization models, beyond basic audio advertising.

 

faidr is available today through the iOS and Android app stores.

 

Software Products and Services

  

The faidr App

 

The faidr App is our flagship product and is expected to generate the majority of the Company’s future revenue.

 

 

 

 2 

 

 

How the faidr App Works

 

A faidr subscriber will select a specific streaming radio station to record and be able to listen to the recording of that station in a customized manner. The faidr App will record the station in real time and its AI algorithm will identify the beginning and end of audio content segments including music and commercials. When the recorded station is played back by the App subscriber, faidr will identify the audio content segments the user chooses not to consume and automatically switch the audio playback of the recording to a different piece of audio content. For example, if a consumer chooses not to listen to commercials during the playback of their recording of a station, the faidr App will automatically cover the commercial segments with other content such as additional music.

 

The Company is developing strategies and content relationships to access additional content sources to cover commercials and respond to skips across many content segments in addition to music and commercials, such as sports, news, talk and weather. As the audio content ecosystem continues to expand, the Company believes faidr will represent an attractive distribution platform for content providers. There is no guarantee the audio content ecosystem will continue to expand along its current trajectory or that the Company will be able to secure access to content in an economically advantageous manner, both of which would negatively impact the user experience within faidr. The Company has not yet secured the rights from content providers to place any audio content into the platform in an on-demand use case.

 

Users of faidr can also access any podcast that’s publicly available as well as exclusive programming, music stations and Music Casts, through faidrRadio.

 

The faidr App is built on a proprietary artificial intelligence platform developed and owned by the Company and subject to one issued patent and additional patent applications that are pending.

 

Copyright Law

 

To secure the rights to stream music and other content through the faidr app, the Company may enter into license agreements with copyright owners of sound recordings and musical works or their authorized agents. In June 2021, the Company filed a Notice of Use of Sound Recordings Under Statutory License in accordance with 37 CFR § 370.2, which authorized the Company to make noninteractive digital audio transmissions and reproductions of certain sound recordings pursuant to the statutory licenses set forth in 17 U.S.C. §§ 112 and 114. The Company is also in the process of obtaining licenses with the performing rights organizations (“PROs”) in the United States, which negotiate blanket licenses with copyright users for the public performance of compositions in their repertory, collect royalties under such licenses, and distribute those royalties to copyright owners. 

 

The faidr App’s architecture presents a built-in digital audio recorder (“DAR”) that will allow consumers to record third-party transmissions made available through the faidr App. The Company believes such consumer-initiated recordings are authorized as non-infringing, fair use time shifting by consumers pursuant to the Supreme Court’s decision in Sony Corp. of America v. Universal City Studios, Inc., 464 U.S. 417 (1984). The Supreme Court also ruled that the manufacturers of home video recording devices were not liable for reproductions made by consumers where the devices had substantial non-infringing uses. faidr’s DAR is analogous to the Betamax television recorders found non-infringing in the Universal City Studios decision. With the faidr’s DAR, users can select radio stations to record. Users can also control their listening experience by deciding whether they will listen to commercials or other programming categories selected by the user. The Company believes giving users the ability to avoid commercials is protected, non-infringing activity.

 

If a court were to hold that one or more functionalities offered by the faidr App resulted in the violation of protected rights of third parties, the Company could be subject to liability for infringement, the damages for which could be material.

 

Podcast Platform

 

Auddia’s Podcast Platform, which includes the Vodacast mobile app, is an interactive podcasting platform the Company has built that allows podcasters to give their audiences an interactive audio experience. Podcast listeners are able to see video and other digital content that correlates with the podcast audio and is presented to the listener as a digital feed. All content presented in the digital feed can be synched to the podcast audio content. This allows podcast listeners to visually experience, interact with, and eventually comment on audio content in podcasts.

 

Much of the technology we use in this platform to create the feed of digital content synchronized to the audio content of the podcast is based on the core functionality and product concepts the Company has used historically to provide synchronized digital feeds to over 580 radio stations.

 

 

 3 

 

 

The digital feed introduces a new digital revenue stream to podcasters, such as synchronized digital advertising while providing end users a new digital content channel that compliments the core audio channel of the podcast. Below are hypothetical screenshots for a generic Podcast. The image on the right is an example of an episode feed in the Vodacast mobile app while the image on the left is an example of a typical user experience of a podcast episode in most other listening apps. Within the Vodacast episode feed, digital ads can be placed to drive revenue.

 

All of the content and functionality that is made available within the Podcast Platform, through the Vodacast mobile app, is currently being added to the faidr app, diversifying the podcast offering of faidr and bringing that app up to parity with the major, competing apps like iHeart Radio, TuneIn and Audacy.

 

Business Model and Customer Acquisition Strategy for faidr

 

The Company has an eight-year plus history of working closely with the broadcast radio industry in the United States to help the industry adapt to both digital advertising and digital media technologies.

  

The Company announced several broadcast radio partnerships during 2021 in which we performed commercial trials within these markets. Based on the initial results from our commercial trials, the Company believes consumers are drawn to an interruption-free radio experience. We executed a full launch in February 2022 that initially included approximately 4,000 radio stations on the faidr App. The Company has continued to add stations to the faidr App which now presents more than 6,200 AM/FM streams.

 

Radio stations owned by broadcasters will be economically incentivized to promote faidr to their listeners. We intend to leverage subscription revenue to compensate participating radio broadcasters for promotional support and their increased music streaming fees. We believe that if participating broadcasters can generate increased revenue from their content, they can decrease their on-air advertising load while increasing the price paid for each commercial, as the commercial is more likely to be heard by consumers in a less cluttered advertising environment. In addition, we intend to offer tiered subscriptions to the faidr App where lower priced subscriptions allow a lower level of functionality and control. We believe that our history and existing relationships with broadcast radio will drive customer acquisition for the faidr App.

 

Our business model is based on creating a pool of subscription revenue across all streaming stations and other content providers utilizing the faidr platform. This subscription pool, less direct subscriber acquisition costs and increased music streaming fees, is expected to be shared with radio stations and other content providers based on the time each listener spends listening to a station on faidr. We believe this business model will result in broadcasters promoting the listening of their stations within faidr, similar to how radio stations are currently using airtime to promote the listening of their stations on Alexa and other smart speaker systems.

 

The podcast platform, once implemented in faidr, will be marketed to podcasters and podcasting companies with business-to-business strategies that focus on communicating the value proposition. The potential to earn new, incremental revenue on the faidr platform, in addition to the other key value propositions of the platform, is expected to organically drive podcasters to promote the platform directly to their listeners. Direct-to-consumer marketing will be done independently by the Company and, in some cases, in partnership with podcasters who leverage their audio content programs to promote to their established audiences. As is the case with other proven marketing strategies, we intend to have our partners benefit from a participative revenue share, higher ad revenue, and higher margins on advertising through the Vodacast platform.

 

Risks associated with our business

 

Investing in our securities involves a high degree of risk. You should carefully consider the risks described in “Risk Factors” beginning on page 9 before making a decision to invest in our common stock. If any of these risks actually occurs, our business, financial condition, results of operations and prospects would likely be materially, adversely affected. In that event, the trading price of our common stock could decline, and you could lose part or all of your investment.

 

Going Concern Opinion

 

Our working capital deficiency, stockholders’ deficit, and recurring losses from operations raise substantial doubt about our ability to continue as a going concern. As a result, our independent registered public accounting firm included an explanatory paragraph in its report on our financial statements for the year ended December 31, 2022 with respect to this uncertainty. Our ability to continue as a going concern will require us to obtain additional funding.

 

 

 4 

 

 

Implications of being an emerging growth company

 

We qualify as an “emerging growth company” as defined in the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”). An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. These provisions include:

 

  · inclusion of only two years, as compared to three years, of audited financial statements in addition to any required unaudited interim financial statements with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure;
     
  · an exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);
     
  · an exemption from compliance with any new requirements adopted by the Public Company Accounting Oversight Board (the “PCAOB”) requiring mandatory audit firm rotation;
     
  · reduced disclosure about executive compensation arrangements; and
     
  · an exemption from the requirement to seek non-binding advisory votes on executive compensation or golden parachute arrangements.

 

We may take advantage of these provisions until we are no longer an emerging growth company. We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of our February 2021 IPO, (b) in which we have total annual gross revenue of at least $1.07 billion or (c) in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior December 31st, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.

 

We have taken advantage of the reduced reporting requirements in this prospectus and in the documents incorporated by reference into this prospectus. Accordingly, the information contained herein may be different from the information you receive from other public companies that are not emerging growth companies.

 

The JOBS Act permits an emerging growth company such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies.

 

Our corporate information

 

We were originally formed as Clip Interactive, LLC in January 2012, as a limited liability company under the laws of the State of Colorado. Immediately prior to our initial public offering in February 2021, we converted into a Delaware corporation pursuant to a statutory conversion and were renamed Auddia Inc.

 

Our principal executive offices are located at 2100 Central Ave., Suite 200, Boulder, CO 80301. Our main telephone number is (303) 219-9771. Our internet website is www.auddia.com. The information contained in, or that can be accessed through, our website is not incorporated by reference and is not a part of this prospectus.

 

Trademarks

 

The Company also holds the trademark for “AUDDIA” which is used as both the corporate brand name as well as the name of the consumer-facing mobile application that delivers the Company’s commercial free radio service.  The Company also holds trademarks and is in the process of applying for trademarks for key products and brands. The Company holds the trademark for our product named “PLAZE”, which is a potential commercial-free music streaming product that is a potential future, strategic opportunity of our business. The Company holds the trademark for “VODACAST” which is used as the brand name for our podcasting platform.

 

We have omitted the ® and ™ designations, as applicable, for the trademarks used in this prospectus.

 

 

 5 

 

 

INFORMATION REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus and the documents incorporated by reference in this prospectus include forward-looking statements, which involve risks and uncertainties. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believe,” “estimate,” “project,” “anticipate,” “expect,” “seek,” “predict,” “continue,” “possible,” “intend,” “may,” “might,” “will,” “could,” would” or “should” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this prospectus and the documents incorporated by reference in this prospectus, and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our product candidates, research and development, commercialization objectives, prospects, strategies, the industry in which we operate and potential collaborations. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements.

 

Forward-looking statements speak only as of the date of this prospectus. You should not put undue reliance on any forward-looking statements. We assume no obligation to update forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

 

You should read this prospectus, the documents incorporated by reference in this prospectus, and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance and events and circumstances may be materially different from what we expect. All forward-looking statements are based upon information available to us on the date of this prospectus.

 

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition, business and prospects may differ materially from those made in or suggested by the forward-looking statements contained in this prospectus. In addition, even if our results of operations, financial condition, business and prospects are consistent with the forward-looking statements contained (or incorporated by reference) in this prospectus, those results may not be indicative of results in subsequent periods.

 

Forward-looking statements necessarily involve risks and uncertainties, and our actual results could differ materially from those anticipated in the forward-looking statements due to a number of factors, including those set forth below under “Risk Factors” and elsewhere in this prospectus. The factors set forth below under “Risk Factors” and other cautionary statements made in this prospectus should be read and understood as being applicable to all related forward-looking statements wherever they appear in this prospectus. The forward-looking statements contained in this prospectus represent our judgment as of the date of this prospectus. We caution readers not to place undue reliance on such statements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained above and throughout this prospectus.

 

You should read this prospectus, the documents incorporated by reference in this prospectus, and the documents that we reference in this prospectus and have filed as exhibits to the registration statement of which this prospectus is a part completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

  

 

 6 

 

 

THE OFFERING

 

Units offered

6,819,732 units on a firm commitment basis at an assumed public offering price of $0.8798 per unit. Each unit consists of one share of common stock and one Common Warrant to purchase one share of common stock.

 

We are also offering to each purchaser, with respect to the purchase of units that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of our outstanding shares of common stock immediately following the consummation of this offering, the opportunity to purchase one Pre-Funded Warrant in lieu of one share of common stock. A holder of Pre-Funded Warrants will not have the right to exercise any portion of its Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own in excess of 4.99% (or, at the election of the holder, such limit may be increased to up to 9.99%) of the number of shares of common stock outstanding immediately after giving effect to such exercise. Each Pre-Funded Warrant will be exercisable for one share of common stock. The purchase price per Pre-Funded Warrant will be equal to the price per share of common stock, minus $0.0001, and the exercise price of each Pre-Funded Warrant will equal $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time in perpetuity until all of the Pre-Funded Warrants are exercised in full. The units will not be certificated or issued in stand-alone form. The shares of common stock, and/or Pre-Funded Warrants, and the Common Warrants comprising the units are immediately separable upon issuance and will be issued separately in this offering

   
Common stock to be outstanding prior to this offering 12,850,709 shares
   
Common stock to be outstanding after this offering 19,670,441 shares
   
Assumed public offering price per unit $0.8798 per unit
   

Description of Common Warrants:

 

The Common Warrants will be immediately exercisable on the date of issuance and expire on the five-year anniversary of the date of issuance at an initial exercise price per share equal to $[·] (equal to 100% of the public offering price of each unit sold in this offering), subject to appropriate adjustment in the event of recapitalization events, stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common stock. The terms of the Common Warrants will be governed by a Warrant Agency Agreement, dated as of the closing date of this offering, that we expect to be entered into between us and VStock Transfer LLC or its affiliate (the “Warrant Agent”). This prospectus also relates to the offering of the shares of common stock issuable upon exercise of the Common Warrants. For more information regarding the Common Warrants, you should carefully read the section titled “Description of Securities We Are Offering” in this prospectus.

   
Over-allotment Option We have granted the underwriters an option to purchase an additional [·] shares of common stock and/or Common Warrants to purchase [·] additional shares of common stock from us (being up to 15% of the shares of common stock (including shares underlying Pre-Funded Warrants) and/or up to 15% of the Common Warrants sold in this offering), in any combination thereof, at the public offering price per share and public offering price per Common Warrant, respectively, less the underwriting discounts and commissions, for 45 days from the date of this prospectus.

 

 

 7 

 

 

Use of Proceeds

We expect to receive net proceeds from this offering of approximately $5.3 million, or approximately $6.2 million if the underwriters exercise their option to purchase additional shares of our common stock in full, based upon an assumed offering price of $0.8798 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us

 

We intend to use the net proceeds from this offering (including any additional proceeds that we may receive if the underwriters exercise their option to purchase additional shares of our common stock), together with our existing cash, to (i) pay off $2.2 million principal amount of our outstanding secured bridge notes and (ii) build out the product platforms, expand our sales and marketing efforts, and for general and administration expenses and other general corporate purposes. See “Use of Proceeds.”

   
Nasdaq Capital Market Symbols Common Stock “AUUD”.  Series A Warrants “AUUDW”.
   
Risk Factors Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 9 of this prospectus for a discussion of factors you should carefully consider before deciding to invest in our securities.
   
Lock-up We, each of our officers, directors, and certain of our stockholders of our common stock have agreed, subject to certain exceptions, not to sell, offer, agree to sell, contract to sell, hypothecate, pledge, grant any option to purchase, make any short sale of, or otherwise dispose of or hedge, directly or indirectly, any shares of our capital stock or any securities convertible into or exercisable or exchangeable for shares of capital stock, for a period of ninety (90) days after the date of this prospectus, without the prior written consent of Ladenburg Thalmann & Co. Inc. See “Shares Eligible for Future Sale” and “Underwriting” for additional information.

 

The number of shares outstanding after this offering is based on 12,850,709 shares of our common stock outstanding as of March 10, 2023, and excludes:

 

  · 292,843 shares of our common stock reserved for issuance under outstanding stock options granted under our 2013 Equity Incentive Plan,
  · 275,250 shares of our common stock reserved for issuance under outstanding restricted stock units granted under our 2020 Equity Incentive Plan,
  · 1,044,080 shares of our common stock reserved for issuance under outstanding stock options granted under our 2020 Equity Incentive Plan,
  · 1,143,803 shares of our common stock reserved for future grant under our 2020 Equity Incentive Plan,
  · 511,450 shares of our common stock reserved for issuance under outstanding stock options and outstanding RSUs granted as employment inducement awards to three of our former and current executives outside of our 2013 and 2020 Equity Incentive Plans,
  · 653,855 shares of common stock reserved for issuance upon the exercise of outstanding common stock warrants,
  · 3,498,898 shares of common stock reserved for issuance upon the exercise of our publicly traded outstanding Series A Warrants,
  · 319,346 shares of common stock reserved for issuance upon the exercise of an outstanding IPO underwriter representative common stock warrant, and
  · assumes no exercise by the underwriters of their option to purchase 1,022,960 additional shares and/or Common Warrants pursuant to their over-allotment option.

 

 

 8 

 

 

RISK FACTORS

 

Investing in our securities involves a high degree of risk. You should carefully consider the risks and uncertainties described below, as well as those risk factors included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and any subsequent Quarterly Report on Form 10-Q, together with all of the other information contained in this prospectus and incorporated by reference herein, including our financial statements and the related notes, before deciding to invest in our securities. The risks and uncertainties described below and in the documents incorporated by reference herein are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks actually occurs, our business, financial condition, results of operations and prospects could be materially and adversely affected, the trading price of our common stock could decline and you could lose all or part of your investment.

 

 

Risks Related to Our Financial Condition and Capital Requirements

 

Our continuing operations will require additional capital which we may not be able to obtain on favorable terms, if at all.

 

We currently have limited committed sources of capital and we have limited liquidity. Our cash and cash equivalents as of December 31, 2022, was $1.66 million. We expect our current cash and cash equivalents will be sufficient to fund our operations through the first week of April 2023. Therefore, we will require substantial future capital in order to continue to operations.

 

Following the receipt of $5.3 million in net proceeds from this offering and the repayment of $2.2. million of our outstanding secured bridge note, we believe our cash resources would be sufficient to fund our current operating plans into the 2023 fourth quarter. We have based these estimates, however, on assumptions that may prove to be wrong, and we could spend our available financial resources much faster than we currently expect and need to raise additional funds sooner than we anticipate. If we are unable to raise additional capital when needed or on acceptable terms, we would be forced to delay, reduce, or eliminate our technology development and commercialization efforts.

 

Our stockholders may experience significant dilution as a result of shares of our common stock issued pursuant to our existing equity line financing agreements and also pursuant to new securities that we may issue in the future.

 

We may issue substantial amounts of additional common stock in connection with our existing equity line of credit agreement entered into on November 14, 2022. This financing agreement contains variable pricing mechanisms. The number of shares that we may issue pursuant to this agreement fluctuate based on the price of our common stock. We may also issue additional common stock or securities convertible into or exchangeable or exercisable for common stock, in connection with future capital raising transactions.

 

Risks Relating to this Offering

 

You will experience immediate dilution as a result of this offering and may experience additional dilution in the future.

 

The public offering price for shares of our common stock offered hereby will be substantially higher than the net tangible book value per share of our common stock immediately after this offering. If you purchase common stock in this offering, you will incur substantial and immediate dilution in the net tangible book value of your investment. Net tangible book value per share represents the amount of total tangible assets less total liabilities, divided by the number of shares of our common stock then outstanding. To the extent that options that are currently outstanding are exercised, there will be further dilution to your investment. We may also issue additional common stock, options and other securities in the future that may result in further dilution of your shares of our common stock.

 

We may fail to continue to meet the listing standards of The Nasdaq Capital Market whether or not this offering occurs. Even if this offering occurs, this offering could cause our stock price to fall, which could result in us being delisted from The Nasdaq Capital Market. Failure to maintain the listing of our common stock with a U.S. national securities exchange could adversely effect the liquidity off our common stock.

 

Our common stock is currently listed on The Nasdaq Capital Market. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including maintaining a minimum share price. For example, the current continued listing requirements of Nasdaq provide, among other things, that a company may be delisted if the bid price of its stock drops below $1.00 for a period of 30 consecutive business days. From time to time in the past, our common stock has traded at a bid price below $1.00.

 

If we fail to satisfy the continued listing requirements of Nasdaq, such as the minimum share price requirement, Nasdaq may take steps to delist our securities. Such a delisting would likely have a negative effect on the price and liquidity of our common stock and would impair your ability to sell or purchase our common stock when you wish to do so. In the event of a delisting, we would take actions to restore our compliance with Nasdaq’s listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our common stock from dropping below the Nasdaq minimum share price requirement or prevent future non-compliance with Nasdaq’s listing requirements.

 

 

 9 

 

 

If our common stock were to be delisted from Nasdaq, our common stock could begin to trade on one of the markets operated by OTC Markets Group, including OTCQX, OTCQB or OTC Pink (formerly known as the “pink sheets”), as the case may be. In such event, our common stock could be subject to the “penny stock” rules which, among other things, require brokers or dealers to approve investors’ accounts, receive written agreements and determine investor suitability for transactions and disclose risks relating to investing in the penny stock market. Any such delisting of our common stock could have an adverse effect on the market price of, and the efficiency of the trading market for our common stock, not only in terms of the number of shares that can be bought and sold at a given price, but also through delays in the timing of transactions and less coverage of us by securities analysts, if any. Also, if in the future we were to determine that we need to seek additional equity capital, it could have an adverse effect on our ability to raise capital in the public or private equity markets. In addition, there can be no assurance that our common stock would be eligible for trading on any such alternative exchange or markets.

 

Future sales of our common stock, or the perception that such sales may occur, could depress the trading price of our common stock.

 

After the completion of this offering (and assuming no exercise of the Common Warrants or the Pre-Funded Warrants), we expect to have 19,670,441 shares (20,693,401 shares if the underwriter exercises its option to purchase additional units in full) of our common stock outstanding, which may be resold in the public market immediately after this offering. We and all of our directors and executive officers, and certain of our stockholders, have signed lock-up agreements for a period of 90 days following the date of this prospectus, subject to specified exceptions. See “Underwriting.”

 

The underwriter may, in its sole discretion and without notice, release all or any portion of the shares of our common stock subject to lock-up agreements. As restrictions on resale end, the market price of our common stock could drop significantly if the holders of these shares of our common stock sell them or are perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of our common stock or other securities.

 

We have broad discretion in the use of the net proceeds we receive from this offering and may not use them effectively.

 

Our management will have broad discretion in the application of the net proceeds we receive in this offering, including for any of the purposes described in the section entitled “Use of Proceeds,” and you will not have the opportunity as part of your investment decision to assess whether our management is using the net proceeds appropriately. Because of the number and variability of factors that will determine our use of our net proceeds from this offering, their ultimate use may vary substantially from their currently intended use. The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business and cause the price of our common stock to decline. Pending their use, we may invest our net proceeds from this offering in short-term, investment-grade, interest-bearing securities. These investments may not yield a favorable return to our stockholders.

 

MARKET AND INDUSTRY DATA

 

Unless otherwise indicated, information contained (or incorporated by reference) in this prospectus concerning our industry and the markets in which we operate is based on information from independent industry and research organizations, other third-party sources and management estimates. Management estimates are derived from publicly available information released by independent industry analysts and third-party sources, as well as data from our internal research, and are based on assumptions made by us upon reviewing such data and our knowledge of such industry and markets which we believe to be reasonable. Although we believe the data from these third-party sources is reliable, we have not independently verified any third-party information. In addition, projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty and risk due to a variety of factors, including those described in "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements." These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

 

 

 

 

 10 

 

 

USE OF PROCEEDS

 

We expect to receive net proceeds from this offering of approximately $5.3 million, or approximately $6.2 million if the underwriters exercise their option to purchase additional shares and Common Warrants in full, assuming a public offering price of $0.8798 per unit, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 

Each $0.20 increase (decrease) in the assumed public offering price of $0.8798 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, would increase (decrease) the net proceeds to us by approximately $1.3 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase (decrease) of 700,000 shares in the number of shares offered by us would increase (decrease) the net proceeds to us by approximately $0.6 million, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us.

 

We intend to use the net proceeds from this offering, together with our existing cash, to repay $2.2 million aggregate principal amount of our outstanding secured promissory notes, build out and complete our product offerings, expand our sales and marketing efforts, and for general and administration expenses.

 

Our expected use of net proceeds from this offering represents our current intentions based upon our present plans and business condition. As of the date of this prospectus, we cannot predict with complete certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the actual amounts that we will spend on the uses set forth above. We believe opportunities may exist from time to time to expand our current business through the acquisition or in-license of complementary product candidates. While we have no current agreements for any specific acquisitions or in-licenses at this time, we may use a portion of the net proceeds for these purposes.

 

Pending the uses described above, we plan to invest the net proceeds from this offering in short- and intermediate-term, interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government.

 

DIVIDEND POLICY

 

We have not declared or paid any cash dividends on our capital stock since our inception. We intend to retain future earnings, if any, to finance the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.

 

CAPITALIZATION

 

Except as otherwise noted, all information in this prospectus reflects and assumes (i) no sale of Pre-Funded Warrants in this offering, which, if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no exercise of the Common Warrants issued in this offering.

 

The following table describes our cash and capitalization as of December 31, 2022:

 

  · On an actual basis; and

 

  · on an as adjusted basis to give effect to (i) the sale of 6,819,732 units of our common stock in this offering, assuming a public offering price of $0.8798 per unit (the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023) and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us; and (ii) the repayment of $2.2 million of our secured bridge note.

 

 

 

 11 

 

 

The as adjusted information below is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual public offering price and other terms determined at pricing. You should read this information together with our financial statements and related notes incorporated by reference in this prospectus and the information set forth under the headings “Use of Proceeds” in this prospectus and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report for the year ended December 31, 2022 incorporated by reference in this prospectus.

 

    As of December 31, 2022  
    Actual     As Adjusted  
Cash   $ 1,661,434     $ 4,791,434  
Restricted cash                
Shareholders' equity:                
Preferred stock - $0.001 par value, 10,000,000 authorized, actual and as adjusted, and 0 shares issued and outstanding, actual or as adjusted            
Common stock - $0.001 par value, 100,000,000 authorized, actual and as adjusted; 12,654,949 shares issued and outstanding, actual; 19,474,681 shares issued and outstanding, as adjusted     12,654       19,474  
Additional paid-in capital     75,573,263       80,870,465  
Accumulated deficit     71,735,834       72,133,900  
Total shareholders’ equity     3,850,083       8,756,039  
                 
Total liabilities and shareholders’ equity   $ 6,111,526     $ 9,241,526  

 

Each $0.20 increase (decrease) in the assumed public offering price of $0.8798 per share, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, would increase (decrease) the as adjusted amount of additional paid-in capital, total stockholders’ equity and total capitalization by approximately $1.3 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase (decrease) of 700,000 shares in the number of shares offered by us would increase (decrease) the as adjusted amount of each of additional paid-in capital, total stockholders’ equity and total capitalization by approximately $0.6 million, assuming that the assumed price to the public remains the same, and after deducting the estimated underwriting discounts and commissions and estimated expenses payable by us.

  

The number of shares of common stock issued and outstanding, actual and as adjusted, in the table above is based on 12,654,949 shares of our common stock outstanding as of December 31, 2022, and excludes:

 

  · 292,843 shares of our common stock reserved for issuance under outstanding stock options granted under our 2013 Equity Incentive Plan,

 

  · 563,858 shares of our common stock reserved for issuance under outstanding restricted stock units granted under our 2020 Equity Incentive Plan,

 

  · 1,046,580 shares of our common stock reserved for issuance under outstanding stock options granted under our 2020 Equity Incentive Plan,

 

  · 511,056 shares of our common stock reserved for future grant under our 2020 Equity Incentive Plan,

 

  · 323,750 shares of our common stock reserved for issuance under outstanding stock options and outstanding RSUs granted as employment inducement awards to two of our former and current executives outside of our 2013 and 2020 Equity Incentive Plans,

 

  · 653,855 shares of common stock reserved for issuance upon the exercise of outstanding common stock warrants,

 

  · 3,498,898 shares of common stock reserved for issuance upon the exercise of our publicly traded outstanding Series A Warrants,

 

  · 319,346 shares of common stock reserved for issuance upon the exercise of an outstanding IPO underwriter representative common stock warrant, and

 

  · assumes no exercise by the underwriters of their option to purchase 1,022,960 additional shares and/or Common Warrants pursuant to their over-allotment option.

 

 

 12 

 

 

DILUTION

 

Except as otherwise noted, all information in this prospectus reflects and assumes (i) no sale of Pre-Funded warrants in this offering, which, if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no exercise of the Common Warrants issued in this offering.

 

If you invest in our units in this offering, your ownership interest will be diluted to the extent of the difference between the assumed public offering price per unit and the as adjusted net tangible book value per share of our common stock immediately after this offering.

 

Historical net tangible book value (deficit) per share is determined by dividing our total tangible assets less our total liabilities by the total number of shares of common stock outstanding. Our historical net tangible book value (deficit) as of December 31, 2022, was approximately $(0.5) million, or $(0.0401) per share, based on 12,654,949 shares of common stock outstanding as of that date.

 

After giving effect to receipt of the net proceeds from our sale of 6,819,732 units in this offering at an assumed public offering price of $0.8798 per unit, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us; and (ii) the repayment of our $2.2 million secured bridge note, our as adjusted net tangible book value as of December 31, 2022 would have been approximately $4.4 million, or $0.2259 per share. This represents an immediate increase in as adjusted net tangible book value of $0.2659 per share to our existing stockholders and an immediate dilution of $0.6539 per share to new investors participating in this offering.

 

The following table illustrates this dilution per share:

 

Assumed public offering price per unit            
Historical net tangible book value per share as of December 31, 2022   $ (0.0401 )        
Increase in net tangible book value per share attributable to new investors participating in this offering   $ 0.2659          
As adjusted net tangible book value per share after this offering             0.2259  
Dilution per share to new investors participating in this offering           $ 0.6539  

 

Each $0.20 increase (decrease) in the assumed public offering price of $0.8798 per unit, the last reported sale price of our common stock on the Nasdaq Capital Market on March 24, 2023, would increase (decrease) the as adjusted net tangible book value by $0.0651 per share and the dilution per share to new investors by $0.0651 per share, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us; and (ii) the repayment of $2.2 million of our secured bridge note.

  

We may also increase or decrease the number of units we are offering. Each increase (decrease) of 700,000 units in the number of units we are offering would increase (decrease) our as adjusted net tangible book value by approximately $0.6 million, or $0.0206 ($0.0221) per share, and decrease (increase) the dilution per share to new investors participating in this offering by $0.0206 ($0.0221) per share, assuming that the assumed public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us; and (ii) the repayment of $2.2 million of our secured bridge note. The as adjusted information discussed above is illustrative only and will change based on the actual public offering price, number of shares and other terms determined at pricing.

 

If the underwriters exercise their over-allotment option in full, the as adjusted net tangible book value per share after giving effect to this offering would be $0.2554 per share, which amount represents an immediate increase in the as adjusted net tangible book value of $0.0296 per share of our common stock to existing stockholders and an immediate dilution in net tangible book value of $0.6244 per share of our common stock to new investors purchasing shares of common stock in this offering.

 

The foregoing table and calculations (other than the historical net tangible book value calculation) are based on 12,654,949 shares of common stock outstanding as of December 31, 2022, and excludes:

 

  · 292,843 shares of our common stock reserved for issuance under outstanding stock options granted under our 2013 Equity Incentive Plan,

 

  · 563,858 shares of our common stock reserved for issuance under outstanding restricted stock units granted under our 2020 Equity Incentive Plan,

 

  · 1,046,580 shares of our common stock reserved for issuance under outstanding stock options granted under our 2020 Equity Incentive Plan,

 

  · 511,056 shares of our common stock reserved for future grant under our 2020 Equity Incentive Plan,

 

 

 13 

 

 

  ·

323,750 shares of our common stock reserved for issuance under outstanding stock options and outstanding RSUs granted as employment inducement awards to two of our former and current executives outside of our 2013 and 2020 Equity Incentive Plans,

 

  · 653,855 shares of common stock reserved for issuance upon the exercise of outstanding common stock warrants,

 

  · 3,498,898 shares of common stock reserved for issuance upon the exercise of our publicly traded outstanding Series A Warrants,

 

  · 319,346 shares of common stock reserved for issuance upon the exercise of an outstanding underwriter representative common stock warrant, and

 

  · assumes no exercise by the underwriters of their option to purchase 1,022,960 additional shares and/or Common Warrants pursuant to their over-allotment option.

 

 

DESCRIPTION OF CAPITAL STOCK

 

The following description is intended as a summary of our certificate of incorporation (which we refer to as our “charter”) and our bylaws, each of which is filed as an exhibit to the registration statement of which this prospectus forms a part, and to the applicable provisions of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our charter and bylaws.

 

We have two classes of securities registered under Section 12 of the Exchange Act. Our shares of common stock are listed on The Nasdaq Stock Market under the trading symbol “AUUD.” Our Series A Warrants are listed on the Nasdaq Stock Market under the trading symbol “AUUDW.”

 

Authorized Capital Stock

 

Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.001 per share, and 10,000,000 shares of preferred stock, par value $0.001 per share.

 

Common Stock

 

The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.

 

In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock. Each outstanding share of common stock is duly and validly issued, fully paid and non-assessable.

 

Preferred stock

 

Our board will have the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company or other corporate action.

 

No shares of preferred stock are currently outstanding.

 

 

 14 

 

 

Anti-Takeover Effects of Delaware Law and Provisions of our Charter and our Bylaws

 

Certain provisions of the DGCL and of our charter and our bylaws could have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts. These provisions include the items described below.

 

Delaware Anti-Takeover Statute

 

We are subject to the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:

 

  · before the stockholder became interested, our Board approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;

 

  · upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or

 

  · at or after the time the stockholder became interested, the business combination was approved by our Board and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.

 

Section 203 defines a business combination to include:

 

  · any merger or consolidation involving the corporation and the interested stockholder;

 

  · any sale, transfer, lease, pledge, exchange, mortgage or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;

 

  · subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; or

 

  · the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

 

In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.

 

Board Composition and Filling Vacancies

 

Our charter provides that stockholders may remove directors only for cause and only by the affirmative vote of the holders of at least two-thirds of our outstanding common stock. Our charter and bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors may only be set by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity of management.

 

 

 15 

 

 

No Written Consent of Stockholders

 

Our charter and bylaws provide that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our bylaws or removal of directors by our stockholders without holding a meeting of stockholders.

 

Meetings of Stockholders

 

Our charter and bylaws provide that only a majority of the members of our Board then in office, our Executive Chairman or our Chief Executive Officer may call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders.

 

Advance Notice Requirements

 

Our bylaws provide advance notice procedures for stockholders seeking to bring matters before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our bylaws also specify certain requirements regarding the form and content of a stockholder’s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions might also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.

 

Amendment to our Charter and Bylaws

 

The DGCL, provides, generally, that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation’s certificate of incorporation or bylaws, unless a corporation’s certificate of incorporation or bylaws, as the case may be, requires a greater percentage. Our bylaws may be amended or repealed by a majority vote of our board of directors or the affirmative vote of the holders of at least two-thirds of the votes that all our stockholders would be entitled to cast in an annual election of directors. In addition, the affirmative vote of the holders of at least two-thirds of the votes that all our stockholders would be entitled to cast in an election of directors is required to amend or repeal or to adopt certain provisions of our charter.

 

Undesignated preferred stock

 

Our charter provides for 10,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board could cause shares of convertible preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our charter grants our board broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.

 

 

 

 16 

 

 

Choice of Forum

 

Our charter provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings: any derivative action or proceeding brought on behalf of the Company, any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders, any action asserting a claim against the Company arising pursuant to any provision of the DGCL or the Company’s certificate of incorporation or bylaws, or any action asserting a claim against the Company governed by the internal affairs doctrine. Our charter also provides that unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Despite the fact that the certificate of incorporation provides for this exclusive forum provision to be applicable to the fullest extent permitted by applicable law, Section 27 of the Exchange Act, creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder and Section 22 of the Securities Act, creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. As a result, this provision of the Company’s certificate of incorporation would not apply to claims brought to enforce a duty or liability created by the Exchange Act, or any other claim for which the federal courts have exclusive jurisdiction. However, there is uncertainty as to whether a Delaware court would enforce the exclusive federal forum provisions for Securities Act claims and that investors cannot waive compliance with the federal securities laws and rules and regulations thereunder.

 

Unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.

 

Series A Warrants

 

Each Series A Warrant represents the right to purchase one share of common stock at an exercise price of $4.54. The Series A Warrants are exercisable beginning February 17, 2021 will terminate on the 5th anniversary date the Series A Warrants are first exercisable. The exercise price and number of shares for which each Series A Warrant may be exercised is subject to adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our common stock.

 

Holders of the Series A Warrants may exercise their Series A Warrants to purchase shares of our common stock on or before the termination date by delivering an exercise notice, appropriately completed and duly signed. Payment of the exercise price for the number of shares for which the Series A Warrants is being exercised must be made within two trading days following such exercise. In the event that the registration statement relating to the Series A Warrants shares (the “Warrant Shares”) is not effective, a holder of Series A Warrants may only exercise its Series A Warrants for a net number of Warrant Shares pursuant to the cashless exercise procedures specified in the Series A Warrants. Series A Warrants may be exercised in whole or in part, and any portion of a Series A Warrant not exercised prior to the termination date shall be and become void and of no value. The absence of an effective registration statement or applicable exemption from registration does not alleviate our obligation to deliver common stock issuable upon exercise of a Series A Warrant.

 

Upon the holder’s exercise of a Series A Warrant, we will issue the shares of common stock issuable upon exercise of the Series A Warrant within three trading days of our receipt of notice of exercise, subject to timely payment of the aggregate exercise price therefor.

 

The shares of common stock issuable on exercise of the Series A Warrants will be, when issued in accordance with the Series A Warrants, duly and validly authorized, issued and fully paid and non-assessable. We will authorize and reserve at least that number of shares of common stock equal to the number of shares of common stock issuable upon exercise of all outstanding warrants.

 

If, at any time a Series A Warrant is outstanding, we consummate any fundamental transaction, as described in the Series A Warrants and generally including any consolidation or merger into another corporation, the consummation of a transaction whereby another entity acquires more than 50% of our outstanding common stock, or the sale of all or substantially all of our assets, or other transaction in which our common stock is converted into or exchanged for other securities or other consideration, the holder of any Series A Warrants will thereafter receive upon exercise of the Series A Warrants, the securities or other consideration to which a holder of the number of shares of common stock then deliverable upon the exercise or conversion of such Series A Warrants would have been entitled upon such consolidation or merger or other transaction.

 

 

 17 

 

 

The Series A Warrants are not exercisable by their holder to the extent (but only to the extent) that such holder or any of its affiliates would beneficially own in excess of 4.99% of our common stock.

 

Amendments and waivers of the terms of the Series A Warrants require the written consent of the holder of such Series A Warrants and us. The Series A Warrants will be issued in book-entry form under a warrant agent agreement between V-Stock Transfer Company, Inc. as warrant agent, and us, and shall initially be represented by one or more book-entry certificates deposited with The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

 

You should review a copy of the warrant agent agreement and the form of the Series A Warrants, each of which are included as exhibits to the registration statement of which this prospectus is a part.

 

Transfer Agent, Registrar, Warrant Agent

 

The transfer agent and registrar for our common stock and the warrant agent for our Series A Warrants is VStock Transfer LLC, 18 Lafayette Place, Woodmere, NY 11598.

 

As of March 10, 2023, there were 12,850,709 shares of our common stock outstanding, and approximately 138 stockholders of record. No shares of our preferred stock are designated, issued or outstanding.

 

Other Warrants

 

At March 10, 2023, we had 653,855 outstanding common stock warrants. These warrants have a weighted-average exercise price of $4.81. 353,855 will expire in October 2023 and 300,000 will expire in November 2027.

 

These warrants have a net exercise provision under which its holder may, in lieu of payment of the exercise price in cash, surrender the warrant and receive a net amount of shares based on the fair market value of the underlying shares at the time of exercise of the warrant after deduction of a number of shares equal in value to the aggregate exercise price. The warrants contain provisions for the adjustment of the exercise price and the number of shares issuable upon the exercise of the warrant in the event of certain stock dividends, stock splits, reorganizations, reclassifications and consolidations.

 

Outstanding Stock Options and Restricted Stock Units

 

At March 10, 2023, we had 292,843 outstanding common stock options, with a weighted-average exercise price of $3.65, which were granted under the Clip Interactive, LLC 2013 Equity Incentive Plan. We ceased granting awards under the 2013 Plan upon the implementation of the 2020 Plan described below.

 

At March 10, 2023, we had 511,450 shares of our common stock reserved for issuance under outstanding stock options and outstanding Restricted Stock Units granted as employment inducement awards to three of our former and current executives outside of our 2013 and 2020 Equity Incentive Plans.

 

2020 Equity Incentive Plan

 

The Company’s 2020 Equity Incentive Plan, which became effective upon the completion of the IPO in February 2021, serves as the successor equity incentive plan to the 2013 Plan. The 2020 Plan currently has an aggregate of 2,753,567 shares of common stock authorized for issuance, after giving effect to the “evergreen” increase of 632,747 shares as of January 1, 2023.

 

The 2020 Equity Incentive Plan contains an “evergreen” provision, pursuant to which the number of shares of common stock reserved for issuance pursuant to awards under such plan shall be increased on the first day of each year beginning January 1, 2022 and ending January 1, 2030 equal to the lesser of (a) five percent (5%) of the shares of stock outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (b) such smaller number of shares of stock as determined by our board of directors.

 

At March 10, 2023 under our 2020 Equity Incentive Plan, there were (i) 1,044,080 outstanding common stock options with an exercise price of $1.39 (ii) 275,250 outstanding restricted stock units, and (iii) 1,143,803 shares remaining available for future grant.

 

 

 18 

 

 

DESCRIPTION OF SECURITIES WE ARE OFFERING

 

We are offering units, each unit consisting of one share of common stock and one Common Warrant to purchase one share of common stock. We are also offering to each purchaser whose purchase of shares of common stock in this offering would otherwise result in the purchaser, together with its affiliates, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of our outstanding shares of common stock immediately following the consummation of this offering, the opportunity to purchase, if the purchaser so chooses, units containing Pre-Funded Warrants in lieu of shares of common stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% (or, at the election of the holder, 9.99%) of our outstanding shares of common stock. For each Pre-Funded Warrant we sell (without regard to any limitation on exercise set forth therein), the number of shares of common stock we are offering will be decreased on a one-for-one basis. Because one Common Warrant is being sold together in this offering with each share of common stock or, in the alternative, each Pre-Funded Warrant to purchase one share of common stock, the number of Common Warrants sold in this offering will not change as a result of a change in the mix of the shares of common stock and Pre-Funded Warrants sold.

 

We are also registering the shares of common stock issuable from time to time upon exercise of the Common Warrants and Pre-Funded Warrants included in the units offered hereby. Our units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common stock (or Pre-Funded Warrants) and the Common Warrants comprising our units are immediately separable and will be issued separately in this offering.

 

The following summary of certain terms and provisions of the Pre-Funded Warrants and Common Warrants offered hereby is not complete and is subject to and qualified in its entirety by the provisions of the form of Pre- Funded Warrant, and the form of Common Warrant, which are filed as exhibits to the registration statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions set forth in the form of Pre-Funded Warrant and the form of Common Warrant.

 

Exercisability.   The Pre-Funded Warrants are exercisable at any time after their original issuance until they are exercised in full. The Common Warrants are immediately exercisable at any time after their original issuance up to the date that is five years after their original issuance. Each of the Common Warrants and the Pre-Funded Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the shares of common stock underlying the Common Warrants or Pre-Funded Warrants under the Securities Act is effective and available for the issuance of such shares, or an exemption from registration under the Securities Act is available for the issuance of such shares, by payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares of common stock underlying the Common Warrants or Pre-Funded Warrants under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Common Warrant or Pre-Funded Warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according to the formula set forth in the Common Warrant or Pre-Funded Warrant. No fractional shares of common stock will be issued in connection with the exercise of a Common Warrant or Pre-Funded Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price.

 

 

 

 19 

 


Exercise Limitation.   A holder will not have the right to exercise any portion of the Pre-Funded Warrants or Common Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, upon election by a holder prior to the issuance of any Pre-Funded Warrant or Common Warrant, 9.99%) of the number of shares of our shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrant or Common Warrant. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, upon at least 61 days’ prior notice from the holder to us with respect to any increase in such percentage.

 

Exercise Price.   The exercise price for the Pre-Funded Warrants is $0.0001 per share. The exercise price per whole share of common stock purchasable upon exercise of the Common Warrants is $[·] per share. The exercise price of the Common Warrants may also be reduced to any amount and for any period of time at the sole discretion of our board of directors. The exercise price and number of shares of common stock issuable upon exercise will adjust in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting our shares of common stock.

 

Transferability.   Subject to applicable laws, the Common Warrants and the Pre-Funded Warrants may be offered for sale, sold, transferred or assigned without our consent.

 

Exchange Listing.   We do not intend to apply for the listing of the Common Warrants or Pre-Funded Warrants offered in this offering on any stock exchange. Without an active trading market, the liquidity of the Common Warrants and the Pre-Funded Warrants will be limited.

 

Warrant Agent.   The Common Warrants and Pre-Funded Warrants are expected to be issued in registered form under a warrant agreement between VStock Transfer, LLC, as warrant agent, and us. The Common Warrants and Pre-Funded Warrants shall initially be represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company (DTC) and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

 

Rights as a Stockholder.   Except as otherwise provided in the Common Warrants or the Pre-Funded Warrants or by virtue of such holder’s ownership of our shares of common stock, the holder of a Common Warrant or Pre-Funded Warrant does not have the rights or privileges of a holder of our shares of common stock, including any voting rights, until the holder exercises the Common Warrant or Pre-Funded Warrant.

 

Fundamental Transactions.   In the event of a fundamental transaction, as described in the Common Warrants and the Pre-Funded Warrants and generally including, with certain exceptions, any reorganization, recapitalization or reclassification of our shares of common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares of common stock, or any person or group becoming the beneficial owner of 50% of the voting power represented by our outstanding shares of common stock, the holders of the Common Warrants and the Pre-Funded Warrants will be entitled to receive upon exercise of the Common Warrants or the Pre-Funded Warrants the kind and amount of securities, cash or other property that the holders would have received had they exercised the Common Warrants or the Pre-Funded Warrants immediately prior to such fundamental transaction. Additionally, as more fully described in the Common Warrant, in the event of certain fundamental transactions, the holders of the Common Warrants will be entitled to receive consideration in an amount equal to the Black Scholes value of the Common Warrants on the date of consummation of such transaction.

 

Governing Law.   The Pre-Funded Warrants, the Common Warrants and Warrant Agreement are governed by New York law.

 

The material terms and provisions of our common stock and each other class of our securities are described under the caption “Description of Capital Stock” in this prospectus.

 

 

 

 

 20 

 

 

SHARES ELIGIBLE FOR FUTURE SALE

 

Future sales of our common stock, including shares issued upon exercise of outstanding options and warrants, in the public market after this offering, or the perception that those sales may occur, could cause the prevailing market price for our common stock to fall or impair our ability to raise equity capital in the future. As described below, only a limited number of shares of our common stock will be available for sale in the public market after consummation of this offering due to contractual and legal restrictions on resale described below. Future sales of our common stock in the public market either before (to the extent permitted) or after restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price of our common stock at such time and our ability to raise equity capital at a time and price we deem appropriate.

 

Sale of outstanding shares

 

Except as otherwise noted, all information in this prospectus reflects and assumes (i) no sale of Pre-Funded Warrants in this offering, which, if sold, would reduce the number of shares of common stock that we are offering on a one-for-one basis and (ii) no exercise of the Common Warrants issued in this offering.

 

Based on the number of shares of our common stock outstanding as of March 10, 2023, upon the closing of this offering, and assuming no exercise of the underwriters’ option to purchase additional shares of common stock and/or Common Warrants, we will have outstanding 19,670,441 shares of common stock.

 

Except for the outstanding shares that are held by our affiliates, substantially all of our outstanding shares may be resold in the public market immediately (i) without any restriction or (ii) with minimal restrictions in compliance with the SEC’s Rule 144 (as described below) as applied to sales by non-affiliates.

 

Unless purchased or held by our affiliates, the 6,819,732 shares sold in this offering, the 6,819,732 shares issuable upon the exercise of the Common Warrants, and the 3,498,898 shares of common stock reserved for issuance upon the exercise of our publicly traded outstanding Series A Warrants may be resold in the public market immediately without any restriction.

 

Any shares of common stock sold in this offering upon exercise of the underwriters’ option to purchase additional shares, will be freely tradable in the public market without restriction or further registration under the Securities Act, unless the shares are held by any of our affiliates.

 

Lock-up agreements

 

In connection with this offering, we, our officers and directors, and certain existing security holders beneficially owning more than 5% of our outstanding common stock agreed that, for a period of 90 days from _______, 2023 (the date of this prospectus), we and they will not, without the prior written consent of Ladenburg Thalmann & Co. Inc., dispose of or hedge any shares or any securities convertible into or exchangeable for our common stock, subject to certain exceptions.

  

Ladenburg Thalmann & Co. Inc., in their sole discretion may release any of the securities subject to these lock-up agreements at any time. If the restrictions under the lock-up agreements are waived, shares of our common stock may become available for resale into the market, subject to applicable law, which could reduce the market price for our common stock. See “Underwriting.”

 

Rule 144

 

In general, under Rule 144, as currently in effect, once we have been subject to the public company reporting requirements of the Exchange Act, for at least 90 days, a person (or persons whose shares are required to be aggregated) who is not deemed to have been one of our “affiliates” for purposes of Rule 144 at any time during the three months preceding a sale, and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six months, including the holding period of any prior owner other than one of our “affiliates,” is entitled to sell those shares in the public market (subject to the lock-up agreements referred to above, if applicable) without complying with the manner of sale, volume limitations or notice provisions of Rule 144, but subject to compliance with the public information requirements of Rule 144.

 

Rule 144(a)(1) defines an “affiliate” of an issuing company as a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such issuer. Directors, officers and holders of ten percent or more of the Company’s voting securities (including securities which are issuable within the next sixty days) are deemed to be affiliates of the issuing company. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than “affiliates,” then such person is entitled to sell such shares in the public market without complying with any of the requirements of Rule 144 (subject to the lock-up agreements referred to above, if applicable).

 

 

 21 

 

 

In general, under Rule 144, as currently in effect, once we have been subject to the public company reporting requirements of the Exchange Act for at least 90 days, our “affiliates,” as defined in Rule 144, who have beneficially owned the shares proposed to be sold for at least six months, including the holding period of any prior owner other than one of our “affiliates,” are entitled to sell in the public market, upon expiration of any applicable lock-up agreements and within any three-month period, a number of those shares of our common stock that does not exceed the greater of:

 

  · 1% of the number of common shares then outstanding; or

 

  · the average weekly trading volume of our common stock on the Nasdaq during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.

 

Such sales under Rule 144 by our “affiliates” or persons selling shares on behalf of our “affiliates” are also subject to certain manner of sale provisions, notice requirements and to the availability of current public information about us.

 

Rule 701

 

The Rule 701 exemption is not available to Exchange Act reporting companies. In general, under Rule 701 as currently in effect, any of our employees, directors, officers, consultants or advisors who acquired common stock from us in connection with a written compensatory stock or option plan or other written agreement in compliance with Rule 701 under the Securities Act before the effective date of our IPO registration statement (to the extent such common stock is not subject to a lock-up agreement) is entitled to rely on Rule 701 to resell such shares beginning 90 days after we become subject to the public company reporting requirements of the Exchange Act. Our affiliates can resell shares in reliance on Rule 144 without having to comply with the holding period requirement, and non-affiliates of the Company can resell shares in reliance on Rule 144 without having to comply with Rule 144’s current public information and holding period requirements in Rule 144. Accordingly, subject to any applicable lock-up agreements, beginning 90 days after our IPO, under Rule 701 persons who are non-affiliates may resell those shares without complying with the minimum holding period or public information requirements of Rule 144, and affiliates of the Company may resell those shares without compliance with Rule 144’s minimum holding period requirements.

  

UNDERWRITING

  

We are offering the units described in this prospectus through the underwriters named below. Ladenburg Thalmann & Co. Inc. is acting as the lead managing underwriter in this offering. Maxim is acting as the lead manager in this offering. Subject to the terms and conditions of the underwriting agreement, dated as of _____, 2023, the underwriters have agreed to purchase the number of our securities set forth opposite its respective name below.

 

Name of Underwriter     Number of Units  
Ladenburg Thalmann & Co. Inc.          
 Maxim Group LLC          
Total          

 

A copy of the underwriting agreement has been filed as an exhibit to the registration statement of which this prospectus is a part.

 

We have been advised by the underwriters that they propose to offer the units directly to the public at the public offering price set forth on the cover page of this prospectus. Any securities sold by the underwriters to securities dealers will be sold at the public offering price less a selling concession not in excess of $____ per share and $ ______ per Common Warrant.

 

The underwriting agreement provides that the underwriters’ obligation to purchase the securities we are offering is subject to conditions contained in the underwriting agreement

 

 

 

 22 

 

 

No action has been taken by us or the underwriters that would permit a public offering of the shares of the units, or the shares of common stock, Pre-Funded Warrants or Common Warrants in any jurisdiction outside the United States where action for that purpose is required. None of our securities included in this offering may be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sales of any of the securities offering hereby be distributed or published in any jurisdiction except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons who receive this prospectus are advised to inform themselves about and to observe any restrictions relating to this offering of securities and the distribution of this prospectus. This prospectus is neither an offer to sell nor a solicitation of any offer to buy the securities in any jurisdiction where that would not be permitted or legal.

 

The underwriters have advised us that they do not intend to confirm sales to any account over which they exercise discretionary authority.

 

Underwriting Discount and Expenses

 

The following table summarizes the underwriting discount and commission to be paid to the underwriters by us. 

 

   Per Unit (1)   Total
Without
Over-
Allotment
Option
   Total With
Full Over-
Allotment
Option
 
Public offering price  $    $    $  
Underwriting discount and commission to be paid to underwriters by us (2)(3)    $    $    $  
Proceeds, before expenses, to us  $    $    $  

  

  (1) The public offering price and underwriting discount in respect of the units corresponds to (i) a public offering price per share of common stock of $[___] ($[___] net of the underwriting discount), and (ii) a public offering price per Common Warrant of $[___] ($[___] net of the underwriting discount). The public offering price for a unit with a Pre-funded Warrant and a Common Warrant shall be $0.0001 less than the public offering price per unit with a share of common stock and a Common Warrant.
  (2) We have also agreed to reimburse the accountable expenses of the representative up to a maximum of $90,000.
  (3) We have granted a 45-day option to the underwriters to purchase up to additional shares of common stock and/or Common Warrants to purchase an additional shares of common stock at the assumed public offering price per share of common stock and the assumed public offering price per Common Warrant set forth above less the underwriting discounts and commissions solely to cover over-allotments, if any.

 

We estimate the total expenses payable by us for this offering to be approximately $______, which amounts includes (i) underwriting discount of $_____, (ii) reimbursement of the accountable expenses of the Representative, including the legal fees of the Representative, in an amount not to exceed $90,000, including the expense deposit of $25,000 paid by us to the Representative, and (iii) other estimated company expenses of approximately $____, which includes legal, accounting, printing costs, and various fees associated with the registration and listing of our shares.

 

Over-Allotment Option

 

We have granted to the underwriters an option, exercisable no later than 45 calendar days after the date of the underwriting agreement, to purchase in the aggregate, up to ____ shares of common stock (the “Option Shares”) and/or Common Warrants to purchase up to ____ shares of common stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the share purchase price and/or warrant purchase price, respectively, less underwriting discounts and commissions. The underwriters may exercise this option only to cover over-allotments, if any, made in connection with this offering. To the extent the option is exercised and the conditions of the underwriting agreement are satisfied, we will be obligated to sell to the underwriters, and the underwriters will be obligated to purchase, these additional shares of common stock.

 

 

 

 23 

 

 

Determination of Offering Price

 

Our common stock is currently traded on The Nasdaq Capital Market under the symbol “AUUD.” On March 24, 2023, the closing price of our common stock was $0.8798 per share.

 

The public offering price of the securities offered by this prospectus will be determined by negotiation between us and the underwriters. Among the factors that will be considered in determining the final public offering price of the shares:

 

  · Our history and our prospects;
  · The industry in which we operate;
  · Our past and present operating results; and
  · The general condition of the securities markets at this time of this offering.

 

The public offering price stated on the cover page of this prospectus should not be considered an indication of the actual value of the shares of common stock sold in this offering. That price is subject to change as a result of market conditions and other factors and we cannot assure you that the shares of common stock sold in this offering can be resold at or above the public offering price.

 

Listing

 

Our shares of common stock are listed on the Nasdaq Capital Market under the symbol “AUUD.”

 

The last reported sales price of our shares of common stock on March 24, 2023 was $0.8798 per share. The actual public offering price per unit will be determined between us, the underwriters and the investors in the offering, and may be at a discount to the current market price of our common stock. Therefore, the assumed public offering price used throughout this prospectus may not be indicative of the final public offering price. There is no established public trading market for the Pre-Funded Warrants or the Common Warrants, and we do not expect such a market to develop. In addition, we do not intend to apply for listing of the Pre-Funded Warrants or the Common Warrants on any securities exchange or other trading system.

 

Lock-Up Agreements

 

We, our officers and directors and certain stockholders have agreed, subject to limited exceptions, for a period of 90 days after the closing of this offering, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of, directly or indirectly any shares of common stock or any securities convertible into or exchangeable for our common stock either owned as of the date of the underwriting agreement or thereafter acquired without the prior written consent of Ladenburg Thalmann & Co. Inc. Ladenburg Thalmann & Co. Inc. may, in its sole discretion and at any time or from time to time before the termination of the lock-up period, without notice, release all or any portion of the securities subject to lock-up agreements. 

 

Other Relationships

 

From time to time, certain of the underwriters and their affiliates may provide in the future, various advisory, investment and commercial banking and other services to us in the ordinary course of business, for which they will receive customary fees and commissions. The lead manager has received compensation for services previously provided to the Company.

 

Transfer Agent, Warrant Agent and Registrar

 

The transfer agent, warrant agent and registrar for our common stock is vStock Transfer LLC, at 18 Lafayette Place, Woodmere, NY 11598. The transfer agent’s telephone number is (212) 828-8436.

 

 

 24 

 

 

Stabilization, Short Positions and Penalty Bids

 

The underwriters may engage in syndicate covering transactions stabilizing transactions and penalty bids or purchases for the purpose of pegging, fixing or maintaining the price of our common stock;

 

·Syndicate covering transactions involve purchases of securities in the open market after the distribution has been completed in order to cover syndicate short positions. Such a naked short position would be closed out by buying securities in the open market. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the securities in the open market after pricing that could adversely affect investors who purchase in the offering.
·Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specific maximum.
·Penalty bids permit the underwriters to reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.

 

These syndicate covering transactions, stabilizing transactions, and penalty bids may have the effect of raising or maintaining the market prices of our securities or preventing or retarding a decline in the market prices of our securities. As a result the price of our common stock may be higher than the price that might otherwise exist in the open market. Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of our common stock. These transactions may be effected on the Nasdaq Capital Market, in the over-the-counter market or on any other trading market and, if commenced, may be discontinued at any time.

 

In connection with this offering, the underwriters also may engage in passive market making transactions in our common stock in accordance with Regulation M during a period before the commencement of offers or sales of shares of our common stock in this offering and extending through the completion of the distribution. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for that security. However, if all independent bids are lowered below the passive market maker’s bid that bid must then be lowered when specific purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.

 

Neither we, nor the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the prices of our securities. In addition, neither we nor the underwriters make any representation that the underwriters will engage in these transactions or that any transactions, once commenced will not be discontinued without notice.

 

Indemnification

 

We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make for these liabilities.

 

LEGAL MATTERS

 

Carroll Legal LLC, Denver, CO will pass upon the validity of the shares of common stock offered hereby for us. The underwriters are represented by Ellenoff Grossman & Schole LLP.

 

 

EXPERTS

 

Daszkal Bolton LLP (“Daszkal”), independent registered public accounting firm, has audited our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, as set forth in their report, which is incorporated by reference in this prospectus and elsewhere in the registration statement. Our financial statements are incorporated by reference in reliance on Daskal’s report, given on their authority as experts in accounting and auditing.

 

 

 25 

 

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of our common stock being offered by this prospectus. This prospectus, which constitutes part of that registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules that are part of the registration statement. Some items included in the registration statement are omitted from the prospectus in accordance with the rules and regulations of the SEC. For further information with respect to us and the common stock offered in this prospectus, we refer you to the registration statement and the accompanying exhibits and schedules filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement.

 

The SEC maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address is www.sec.gov.

 

We also maintain a website at www.auddia.com. The reference to our website address does not constitute incorporation by reference of the information contained on our website, and you should not consider information on our website to be part of this prospectus.

 

You may also request a copy of these filings, at no cost to you, by writing or telephoning us at the following address:

 

Auddia Inc.

Attn: Investor Relations

2100 Central Avenue, Suite 200

Boulder, CO 80301

Telephone: (303) 219-9771

  

 

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

 

The SEC allows us to incorporate by reference the information and reports we file with it, which means that we can disclose important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede the information already incorporated by reference. We are incorporating by reference the documents listed below, which we have already filed with the SEC (SEC File No. 001-40071), and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including all filings made after the date of the filing of this registration statement, except as to any portion of any future report or document that is not deemed filed under such provisions until we sell all of the securities:

 

  · our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 23, 2023;

 

  · our Current Reports on Form 8-K, filed with the SEC, on February 16 and March 9, 2023; and

 

  · the description of our securities registered pursuant to Section 12 of the Exchange Act our Registration Statement on Form 8-A (File No. 001-40071), filed with the SEC under Section 12(b) of the Exchange Act, on February 16, 2021, including any amendment or report filed for the purpose of updating such description.

 

We will furnish without charge to you, on written or oral request, a copy of any or all of the documents incorporated by reference in this prospectus, including exhibits to these documents. You should direct any requests for documents to Auddia Inc., Attn: Investor Relations, 2100 Central Avenue, Suite 200, Boulder, CO 80301; Telephone: (303) 219-9771; E-mail: tackerman@auddia.com.

 

You also may access these filings, free of charge, on the SEC’s website at www.sec.gov or on our website at www.auddia.com. We do not incorporate the information on our website into this prospectus or any supplement to this prospectus and you should not consider any information on, or that can be accessed through, our website as part of this prospectus or any supplement to this prospectus (other than those filings with the SEC that we specifically incorporate by reference into this prospectus or any supplement to this prospectus).

 

Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement.

 

 26 

 

 

 

 

 

6,819,732 UNITS CONSISTING OF

ONE SHARE OF COMMON STOCK

OR PRE-FUNDED WARRANTS TO PURCHASE SHARES

OF COMMON STOCK AND

WARRANTS TO PURCHASE SHARES

OF COMMON STOCK

 

 

 

 

AUDDIA, INC.

 

 

 

 

 

PROSPECTUS

 

 

 

 

 

____________, 2023

 

 

 

Ladenburg Thalmann & Co. Inc. Maxim Group LLC

 

  

 

 

   

 

 

  

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution.

 

The following table sets forth the costs and expenses, other than the underwriting discounts and commissions, payable in connection with the sale of common stock being registered. All amounts shown are estimates, except the Securities and Exchange Commission registration fee, the Financial Industry Regulatory Authority filing fee and the Exchange listing fee.

 

Securities and Exchange Commission registration fee   $ 1,521  
Financial Industry Regulatory Authority filing fee     2,570  
Legal fees and expenses     150,000  
Accountants’ fees and expenses     50,000  
Printing expenses     25,000  
Transfer agent and registrar fees and expenses     15,000  
Miscellaneous     5,909  
Total   $ 250,000   

 

Item 14. Indemnification of Directors and Officers.

 

We are incorporated under the laws of the state of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that his or her conduct was illegal. A Delaware corporation may indemnify any persons who are, or are threatened to be made, a party to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person was a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation’s best interests except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses that such officer or director has actually and reasonably incurred. Our charter and bylaws provide for the indemnification of our directors and officers to the fullest extent permitted under the Delaware General Corporation Law.

 

Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for:

 

  · any breach of the director’s duty of loyalty to the corporation or its stockholders;

 

  · any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

 

  · any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or

 

  · any transaction from which the director derived an improper personal benefit.

 

 

 II-1 

 

 

These limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our charter also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.

 

As permitted by Section 145 of the Delaware General Corporation Law, our bylaws provide that:

 

  · we may indemnify our directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions;
     
  · we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; and
     
  · the rights provided in our bylaws are not exclusive.

 

Section 174 of the Delaware General Corporation Law provides, among other things, that a director who willfully or negligently approves of an unlawful payment of dividends or an unlawful stock purchase or redemption may be held liable for such actions. A director who was either absent when the unlawful actions were approved, or dissented at the time, may avoid liability by causing his or her dissent to such actions to be entered in the books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.

 

As permitted by the Delaware General Corporation Law, we have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. Under the terms of our indemnification agreements, we are required to indemnify each of our directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis of the indemnitee’s involvement was by reason of the fact that the indemnitee is or was a director, or officer, of the company or any of its subsidiaries or was serving at the company’s request in an official capacity for another entity. We must indemnify our officers and directors against (1) attorneys’ fees and (2) all other costs of any type or nature whatsoever, including any and all expenses and obligations paid or incurred in connection with investigating, defending, being a witness in, participating in (including on appeal) or preparing to defend, be a witness or participate in any completed, actual, pending or threatened action, suit, claim or proceeding, whether civil, criminal, administrative or investigative, or establishing or enforcing a right to indemnification under the indemnification agreement. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act.

 

In addition, we have purchased a policy of directors’ and officers’ liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances.

 

The form of Underwriting Agreement, to be filed as Exhibit 1.1 hereto, provides for indemnification by the underwriters of us and our officers who sign this Registration Statement and directors for specified liabilities, including matters arising under the Securities Act.

 

Item 15. Recent Sales of Unregistered Securities.

 

During the three-year period preceding the date of filing of this registration statement, we have issued securities in the transactions described below without registration under the Securities Act.

 

Clip Interactive, LLC

 

Since January 1, 2016, Clip Interactive, LLC issued the following securities that were not registered under the Securities Act:

 

In 2016, 967,895 shares of Series B Preferred Stock were issued for cash proceeds of $1,009,998 at $ 1.0435 per share.

 

In 2017, Convertible Notes in the amount of $4,888,077 plus $190,097 in accrued interest were converted into 4,866,483 shares of Series B at $1.0435 per share. Issuance costs of $46,372 were incurred with the issuance during 2017. Also in 2017, 184,602 shares of Series B were issued at fair value of $192,632 at $1.0435 per share to Clip Digital shareholders (a related party). This transaction was the result of termination of Clip Digital, LLC which triggered investor rights that converted Clip Digital LLC investment amounts into Series B shares of the Company.

 

 

 II-2 

 

 

In 2018 and 2017, 235,967 and 247,246 shares of Series B were issued for subscription receivables and cash of $246,231 and $258,001, respectively, at $1.0435 per share.

 

In 2018, we issued 2,049,396 Series B preferred shares for cash totaling $2,138,545.

 

During 2018, the Company approved a share exchange as described in our financial statements which has been treated in substance as a stock split of 9.07:1.00 for authorized and outstanding shares participating in a pay to play financing with all share and per-share amounts for Series F, Series 1 Common Shares, and options.

 

In 2018, 354,516 and 131,782 shares of Series B were issued in exchange of notes payable to a related party for $370,000 and foregone wages of $137,515 at $1.0435 per share.

 

In 2018, 186,271,597 shares of Series C were issued at $0.115 per share in exchange for 5,300,000 Series A shares and 15,230,334 Series B shares.

 

In 2018, 51,672,086, 4,530,861 and 4,497,827 shares of Series 1 Common Shares were issued at $0.023 per share for cash proceeds of $1,188,458, for conversion of accrued interest of $104,210, and for subscriptions receivable of $103,450, respectively.

 

In 2019, 31,799,648 shares of Series 1 Common shares were issued for cash proceeds of $731,392 at $0.023 per share. A total of 31,666,865 of these Series 1 Common shares issued reduced the Series F shares outstanding so that only 132,783 of the Series 1 Common shares issued were dilutive to the existing shareholders.

 

During 2019, the agreement with a shareholder for a collateral arrangement was converted into a long-term note totaling $725,000 due upon maturity on June 30, 2020. The collateral agreement was extended under similar terms.

 

In 2019, an additional 127,045 shares of Series B were issued at $1.0435 per share or $132,571 to four shareholders in connection with an extension of the 2018 “Pay to Play” financing. The 127,045 shares of Series B were converted into 1,152,675 Series C shares at a conversion of 9.07:1.00 for the Pay to Play as detailed in the notes to our financial statements. The four shareholders received 12,008,057 Series C shares at $0.115 per share in exchange for 1,050,000 Series A shares, 146,450 Series B shares and 127,045 additional Series B shares. The four new shareholder participants also forfeited and exchanged 2,392,900 previously issued Series 1 Common warrants issued in October 2018 for giving consent to the Pay to Play dilution as non-participants and as a result of subsequently electing to participate in 2019 in the extension of the Pay to Play financing, received common warrants totaling 177,323 new Series 1 Common warrants which combined with the Series C preferred shares received resulted in excess incremental fair value over the Series A preferred shares exchanged, resulting in a deemed dividend of approximately $594,000. There was no incremental fair value associated with the holders of Series B preferred shares.

 

In 2019 one additional shareholder that did not participate in the pay to play financing gave his consent to the dilutive financing and received 2,165,426 Series 1 Common warrants price at $0.023 per share. The accounting impact was identical to the previous non-participants that gave consent to the transaction and resulted in a deemed dividend of approximately $44,000.

 

During 2019, the Company began a Convertible Note financing which accrues 6% interest and converts at the effective date of this registration statement at a 30% discount to the IPO price and raised $462,500. Upon the IPO, a beneficial conversion feature was recorded due to the discount estimate of 30%. The amount was recorded as additional interest for the convertible notes on the statement of operations.

 

In October 2019 the Company obtained a $400,000 non interest short term loan from a related party. The Company was advanced $200,000 net of $12,000 in closing fees and the remainder $200,000 was put into an escrow account. On December 2019, the Company made a principal payment of $57,000. The remaining $243,000 of principal and loan financing fees was due on January 30, 2020.

 

In July 2019, the Company initiated a financing in the amount of $2.0 million in the form of a 6% Convertible Promissory Notes due December 31, 2019. In December of 2019, a majority of noteholders voted to extend the due date from December 31, 2019 to March 31, 2020.

 

Subsequent to December 31, 2019, the Company sold $75,000 of 6% Convertible Promissory Notes, due March 31, 2020, to two new investors that convert mandatorily to common stock at a 50% discount to the IPO price. In addition, the Company sold $842,265 of a new of 6% Convertible Promissory Notes, due March 31, 2020, (the 2020 Notes) with a mandatory conversion into common shares at a 75% discount to the IPO price.

 

 

 II-3 

 

 

During 2019, the Company entered into notes payable (the "Notes") with three related parties for $80,000, $200,000 and $50,000, respectively. The $80,000 note was repaid in January 2020. The two other note holders elected to convert their notes into the 2020 Notes, described above.

 

Also subsequent to December 31, 2018, the Company initiated the sale of Series 1 Common shares to existing investors. Sale of the Series 1 Common terminated on November 30, 2019 and raised $477,010. In December 2019, the Company proposed terminating the prior sale of the Series 1 Common and converting the investment into the 2020 Notes. All investors in the Series 1 Common were notified of the proposed change. Unanimous approval was documented by all investors executing subscription agreements terminating their Series 1 Common subscriptions and reallocating their investment into the 2020 Notes.

 

In November 2019, an investor defaulted on 25% or $23,414 of his Equity Note Receivable issued in connection with a financing round completed earlier in 2019. A total of 1,917,992 Series C Preferred shares were cancelled which were previously issued at a conversion rate of 9.07:1.00 for the series A and B preferred shares effectively reversing 25% of the earlier transaction. As a result, the exchange transaction was rescinded resulting in 187,500 shares of Series A Preferred being re-issued at $1.00 per share and 23,896 shares of Series B Preferred shares were re-issued at $1.0435 per share in connection with the default. An additional 203,580 Series C Preferred shares at $0.115/share were also forfeited. The defaulting shareholder was reissued 422,792 shares of Series 1 Common Stock Warrants previously issued for giving consent to the pay to play dilution as a non-participant as a result of subsequently defaulting on his participation. The investor also forfeited 28,934 Series 1 Common Warrants.

 

In 2018, 680,474 options were exercised as severance to purchase Series 1 common stock.

 

Subsequent to December 31, 2019, the Company sold an additional $404,601 of Convertible Notes.

 

Subsequent to December 31, 2019, the Company sold $1,073,244, of a 6% Promissory Notes due December 31, 2021 to a number of existing shareholders in two separate tranches. The notes incorporated the following attributes: interest on the Notes accrues at 6% and if a majority of the noteholders approve, upon the successful completion of a qualified IPO, the notes and accrued interest will convert into equity at per share valuation equal to $40.0 million. In addition, each participant in each tranche would have their original number of shares and warrants doubled.

 

In April 2020, the Company entered into a promissory note evidencing an unsecured loan (the “Loan”) in the amount of $258,662 made to the Company under the Paycheck Protection Program (the “PPP”). The PPP was established under the CARES Act and is administered by the U.S. Small Business Administration. The promissory note matures in April 2022 and bears interest at a rate of 1% per annum. Beginning November 2020, the Company is required to make 18 monthly payments of principal and interest in the amount of $14,370. The Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. The proceeds from the Loan may only be used for payroll costs (including benefits), interest on mortgage obligations, rent, utilities and interest on certain other debt obligations.

 

During the year ended December 31, 2020, the Company sold to investors $404,601 of our convertible notes. All of these convertible notes converted into shares of common stock in connection with our February 2021 IPO.

 

Auddia Inc.

 

In connection with our February 2021 IPO, Clip Interactive LLC converted into a Delaware corporation pursuant to a statutory conversion and changed its name to Auddia Inc. In conjunction with the IPO and corporate conversion, all of our outstanding pre-IPO equity securities, convertible debt securities and certain accrued fees were automatically converted into 7,300,010 shares of common stock. The issuance of such common stock was exempt from the registration requirements of the Securities Act, pursuant to Section 3(a)(9) of the Securities Act, involving an exchange of securities exchanged by the issuer with its existing security holders exclusively where no commission or other remuneration is paid or given directly or indirectly for soliciting such exchange. No underwriters were involved in this issuance of shares.

 

In conjunction with the IPO and corporate conversion, our pre-IPO outstanding options and warrants were converted into (i) stock options for 341,655 common shares and (ii) warrants for 358,334 common shares.

 

On February 19, 2021, pursuant to our IPO Underwriting Agreement, the Company issued a warrant, which enables the representative of our IPO underwriters to purchase up to an aggregate of 319,346 shares of common stock, at an exercise price equal to $5.15625 per share. The representative’s warrant may be exercised beginning on August 19, 2021 (six months after the commencement of sales of the Offering) until February 19, 2026 (five years after the commencement of sales in the Offering).

 

 

 II-4 

 

 

In August 2021 we issued options for 185,000 common shares as an inducement grant outside of our equity plans to a newly hired CFO.

 

In September 2021 we issued 30,000 restricted common shares to a vendor in payment of certain fees.

 

In February 2022, we issued options for 138,750 common shares as an inducement grant outside of our equity plans to a newly hired marketing executive.

 

In November 2022, we entered into a secured bridge note financing with Richard Minicozzi, who is a significant existing stockholder of the Company. The Company received $2,000,000 of gross proceeds in connection with this financing. The principal amount of the secured note is $2,200,000. The secured note has a 10% interest rate and matures on May 31, 2023. The secured note is secured by a lien on substantially all of the Company’s assets. At maturity, Mr. Minicozzi has the option to convert any original issue discount and accrued but unpaid interest into shares of the Company’s common stock. The fixed conversion price is $1.23 per share. In connection with the secured note financing, the Company issued Mr. Minicozzi 300,000 common stock warrants with a five-year term and a fixed $2.10 per share exercise price.

 

In February 2023, we issued options for 150,200 common shares and 37,500 restricted stock units as an inducement grant outside of our equity plans to a newly hired CFO.

 

These sales and issuances were made in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D, Rule 506 (d), and did not involve any underwriters, underwriting discounts or commissions, or any public offering. The persons and entities who received such securities have represented their intention to acquire these securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends are be affixed to all share certificates issued. All recipients have adequate access through their relationship with us to information about us.

 

All of the foregoing securities are deemed restricted securities for purposes of the Securities Act. All certificates representing the restricted shares of capital stock described above, included appropriate legends setting forth that the securities have not been registered and the applicable restrictions on transfer.

 

 

 

 

 

 II-5 

 

 

Item 16. Exhibits and Financial Statement Schedules.

 

(a) Exhibits. The following exhibits are filed as part of this Registration Statement:

 

Exhibit
Number
  Description of Document   Incorporated by reference from Form   Filing
Date
  Exhibit
Number
  Filed
Herewith
                   
                   
1.1   Form of Underwriting Agreement               X
2.2   Form of Plan of Conversion   8-K   02-22-2021   2.1    
3.1   Certificate of Incorporation of the Company   8-K   02-22-2021   3.1    
3.2   Bylaws of the Company   8-K   02-22-2021   3.2    
4.1   Form of Warrant after Conversion from an LLC to a Corporation   S-1/A   01-28-2020   3.5    
4.2   Form of Series A Warrant   S-1/A   02-05-2021   3.6    
4.3   Form of Common Warrant               X
4.4   Form of Pre-Funded Warrant               X
4.5   Form of Common Stock Certificate   S-1/A   10-08-2020   4.1    
4.6   Form of IPO Underwriter Common Stock Purchase Warrant   8-K   02-22-2021   4.1    
4.7   Description of Securities   10-K   03-31-2021    4.3    
5.1 * Opinion of Carroll Legal LLC               X
10.1 # Employment Agreement of Michael T. Lawless   S-1   01-10-2020   10.1    
10.2 # Employment Agreement of Peter Shoebridge   S-1   01-10-2020   10.2    
10.3 # Form of Auddia Inc. 2020 Equity Incentive Plan   S-1/A   10-22-2020   10.3    
10.4   Collateral and Security Agreement with Related Party (Minnicozzi)   S-1/A   01-28-2020   10.4    
10.5   Form of Amendment to Collateral and Security Agreement with Related Party   S-1/A   10-08-2020   10.5    
10.6   Form of Convertible Promissory Note   S-1/A   01-28-2020   10.6    
10.7   Business Loan Agreement and Guaranty of Related Party with Bank of the West   S-1/A   01-28-2020   10.7    
10.8 ** Agreement with Major United States Broadcast Company   S-1/A   01-28-2020   10.8    
10.9   Form of Bridge Note   S-1/A   10-22-2020   10.9    
10.10   Form of Warrant Agent Agreement               X
10.11   Amendment to Bridge Note   S-1/A   10-22-2020   10.14    
10.12   Amended Business Loan Agreement with Bank of the West   10-K   03-31-2021   10.15    
10.13 # First Amendment to 2020 Equity Incentive Plan   S-8   08-10-2021   99.2    
10.14 # Form of Stock Option Grant Notice and Stock Option Agreement under 2020 Equity Incentive Plan   S-8   08-10-2021   99.3    
10.15 # Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under 2020 Equity Incentive Plan   S-8   08-10-2021   99.4    
10.16 # Form of Inducement Stock Option Grant Notice and Inducement Stock Option Agreement   S-8   08-10-2021   99.5    
10.17 # Clip Interactive, LLC 2013 Equity Incentive Plan   S-8   08-10-2021   99.6    
10.18 # Form of Stock Option Grant Notice and Stock Option Agreement under 2013 Equity Incentive Plan   S-8   08-10-2021   99.7    
10.19 # Executive Officer Employment Agreement for Michael Lawless dated October 13, 2021   8-K   10-15-2021   10.1    
10.20 # Executive Officer Employment Agreement for Peter Shoebridge dated October 13, 2021   8-K   10-15-2021   10.2    
10.21 # Executive Officer Employment Agreement for Brian Hoff dated October 13, 2021   8-K   10-15-2021   10.3    
10.22 # Executive Officer Employment Agreement for Timothy Ackerman effective as of February 6, 2023   8-K   02-16-2023   10.1    
10.23   Secured Promissory Bridge Note dated November 14, 2022   8-K   11-14-2022   10.1    
10.24   Common Stock Warrant dated November 14, 2022   8-K   11-14-2022   10.2    
10.25   Security Agreement dated November 14, 2022   8-K   11-14-2022   10.3    
10.26   Common Stock Purchase Agreement, dated November 14, 2022, by and between Auddia Inc. and White Lion Capital LLC   8-K    11-14-2022   10.4    
10.27   Form of Lock-up Agreement               X
23.1   Consent of Daszkal Bolton LLP, Independent Registered Public Accounting Firm               X
23.2 Consent of Carroll Legal LLC (included in Exhibit 5.1)               X
24.1  *** Power of Attorney (included on signature page)              
107   Calculation of Filing Fee Table               X

 

____________________________

* To be filed by amendment to this Registration Statement.
** Certain information contained in this Exhibit has been redacted and appears as “XXXXX” as the disclosure of same would be a disadvantage to the Registrant in the marketplace
*** Previously filed.
# Indicates management contract or compensatory plan.

 

(b) Financial statement schedules. Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the Financial Statements or notes thereto.

 

 

 II-6 

 

 

Item 17. Undertakings.

 

The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

 

Insofar as indemnification by the Registrant for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registration has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

The Registrant hereby undertakes that:

 

(1)For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 

(2)For purposes of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

The undersigned Registrant hereby undertakes that, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

The undersigned Registrant hereby undertakes that, for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

(1) Any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;

 

(2) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;

 

(3) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and

 

(4) Any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.

 

 

 II-7 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Boulder, in the State of Colorado, on this 28th day of March, 2023.

 

  AUDDIA INC.
     
  By:   /s/ Timothy Ackerman
      Timothy Ackerman
      Chief Financial Officer

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Michael Lawless   Chief Executive Officer and Director   March 28, 2023
Michael Lawless   (Principal Executive Officer)    
    President and Director    
         
         
/s/ Timothy Ackerman   Chief Financial Officer   March 28, 2023
Timothy Ackerman   (Principal Financial and Accounting Officer)  
         
         
/s/ Jeffrey Thramann   Executive Chairman and Director   March 28, 2023
Jeffrey Thramann        
         
         
*   Director   March 28, 2023
Stephen Deitsch        
         
         
*   Director   March 28, 2023
Timothy Hanlon        
         
         
*   Director   March 28, 2023
Thomas Birch        

 

 

* By Timothy Ackerman as attorney-in-fact

 

 

/s/ Timothy Ackerman

Timothy Ackerman

 

 

 II-8 

EX-1.1 2 auddia_ex0101.htm FORM OF UNDERWRITING AGREEMENT

Exhibit 1.1

 

____________ SHARES of Common Stock

 

____________ PRE-FUNDED Warrants TO PURCHASE ____________ SHARES OF COMMON STOCK AND

 

____________ Warrants of

 

AUDDIA INC.

 

UNDERWRITING AGREEMENT

 

 

___, 2023

 

Ladenburg Thalmann & Co. Inc.

As the Representative of the

Several underwriters, if any, named in Schedule I hereto 

640 Fifth Avenue, 4th Floor 

New York, New York 10019

 

Ladies and Gentlemen:

 

The undersigned, Auddia Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Auddia Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.

 

It is understood that the several Underwriters are to make a public offering of the Public Securities as soon as the Representative deems it advisable to do so. The Public Securities are to be initially offered to the public at the public offering price set forth in the Prospectus.

 

It is further understood that Ladenburg Thalmann & Co. Inc. will act as the Representative for the Underwriters in the offering and sale of the Closing Securities and, if any, the Option Securities in accordance with this Agreement.

 

ARTICLE I. 

DEFINITIONS

 

1.1              Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:

 

Action” shall have the meaning ascribed to such term in Section 3.1(k).

 

Affiliate” means with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

Board of Directors” means the board of directors of the Company.

 

 

 

   

 

 

Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.

 

Closing” means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.

 

Closing Date” means the hour and the date on the Trading Day on which all conditions precedent to (i) the Underwriters’ obligations to pay the Closing Purchase Price and (ii) the Company’s obligations to deliver the Closing Securities, in each case, have been satisfied or waived, but in no event later than 10:00 a.m. (New York City time) on the second (2nd) Trading Day following the date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.

 

Closing Purchase Price” shall have the meaning ascribed to such term in Section 2.1(b), which aggregate purchase price shall be net of the underwriting discounts and commissions.

 

Closing Securities” shall have the meaning ascribed to such term in Section 2.1(a)(ii).

 

Closing Shares” shall have the meaning ascribed to such term in Section 2.1(a)(i).

 

Closing Common Warrants” shall have the meaning ascribed to such term in Section 2.1(a)(ii).

 

Closing Pre-Funded Warrants” shall have the meaning ascribed to such term in Section 2.1(a)(iii).

 

Closing Warrants” means collectively, the Closing Common Warrants and Closing Pre-Funded Warrants.

 

Combined Purchase Price” shall have the meaning ascribed to such term in Section 2.1(b).

 

Commission” means the United States Securities and Exchange Commission.

 

Common Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

Common Warrants” means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.1(a) hereof, which Warrants shall be exercisable immediately and have a term of exercise equal to five (5) years, in the form of Exhibit C attached hereto.

 

Common Warrant Shares” means the shares of Common Stock issuable upon exercise of the Common Warrants.

 

Company Auditor” means Dazkal Bolton LLP with offices located at 490 Sawgrass Corporate Pkwy, Suite 200, Sunrise, FL 33325.

 

Company Counsel” means Carroll Legal LLC, 1449 Wynkoop Street, Suite 507, Denver, CO 80202.

 

Effective Date” shall have the meaning ascribed to such term in Section 3.1(f).

 

 

 2 

 

 

EGS” means Ellenoff Grossman & Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105.

 

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Execution Date” shall mean the date on which the parties execute and enter into this Agreement.

 

Exempt Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith within 90 days following the Closing Date, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.

 

FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

 

FINRA” means the Financial Industry Regulatory Authority.

 

GAAP” shall have the meaning ascribed to such term in Section 3.1(i).

 

Indebtedness” means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.

 

IP Counsel” means Perkins Coie LLP, with offices located at 1900 Sixteenth Street, Suite 1400, Denver, Colorado 80202.

 

Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

Lock-Up Agreements” means the lock-up agreements that are delivered on the date hereof by each of the Company’s officers and directors and each holder of Common Stock and Common Stock Equivalents outlined on Schedule II hereto, in the form of Exhibit A attached hereto.

 

Material Adverse Effect” means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document.

 

Offering” shall have the meaning ascribed to such term in Section 2.1(c).

 

Option Closing Date” shall have the meaning ascribed to such term in Section 2.2(c).

 

 

 3 

 

 

Option Closing Purchase Price” shall have the meaning ascribed to such term in Section 2.2(b), which aggregate purchase price shall be net of the underwriting discounts and commissions.

 

Option Securities” shall have the meaning ascribed to such term in Section 2.2(a).

 

Option Shares” shall have the meaning ascribed to such term in Section 2.2(a)(i).

 

Option Warrants” shall have the meaning ascribed to such term in Section 2.2(a).

 

Over-Allotment Option” shall have the meaning ascribed to such term in Section 2.2(a).

 

Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Pre-Funded Warrant” means, the Pre-Funded Ordinary Share purchase warrants delivered to the Underwriters in accordance with Section 2.1(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of Exhibit D attached hereto.

 

Pre-Funded Warrant Shares” means the Ordinary Shares issuable upon exercise of the Pre-Funded Warrants.

 

Preliminary Prospectus” means, if any, any preliminary prospectus relating to the Public Securities included in the Registration Statement or filed with the Commission pursuant to Rule 424(b).

 

Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

Prospectus” means the final prospectus filed for the Registration Statement.

 

Prospectus Supplement” means, if any, any supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission.

 

Public Securities” means, collectively, the Closing Securities and, if any, the Option Securities.

 

Registration Statement” means, collectively, the various parts of the registration statement prepared by the Company on Form S-1 (File No. 333-270813) with respect to the Public Securities, each as amended as of the date hereof, including the Prospectus and Prospectus Supplement, if any, the Preliminary Prospectus, if any, and all exhibits filed with or incorporated by reference into such registration statement, and includes any Rule 462(b) Registration Statement.

 

Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

Rule 462(b) Registration Statement” means any registration statement prepared by the Company registering additional Public Securities, which was filed with the Commission on or prior to the date hereof and became automatically effective pursuant to Rule 462(b) promulgated by the Commission pursuant to the Securities Act.

 

SEC Reports” shall have the meaning ascribed to such term in Section 3.1(i).

 

Securities” means the Closing Securities, the Option Securities and the Warrant Shares.

 

 

 4 

 

 

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Share Purchase Price” shall have the meaning ascribed to such term in Section 2.1(b).

 

Shares” means, collectively, the shares of Common Stock delivered to the Underwriters in accordance with Section 2.1(a)(i) and Section 2.2(a).

 

Subsidiary” means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.

 

Trading Day” means a day on which the principal Trading Market is open for trading.

 

Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQX or OTCQB (or any successors to any of the foregoing).

 

Transaction Documents” means this Agreement, the Warrants, the Warrant Agency Agreement, the Lock-Up Agreements, and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

Transfer Agent” means VStock Transfer LLC, the current transfer agent of the Company, with offices located at 18 Lafayette Place, Woodmere, NY 11598, and any successor transfer agent of the Company.

 

Warrant Agency Agreement” means the warrant agency agreement dated on or about the date hereof, among the Company and Vstock Transfer LLC in the form of Exhibit B attached hereto.

 

Warrant Purchase Price” shall have the meaning ascribed to such term in Section 2.1(b).

 

Warrant Shares” means the Ordinary Shares issuable upon exercise of the Warrants.

 

Warrants” means, collectively, the Ordinary Warrants and Pre-Funded Warrants delivered to the Underwriters in accordance with Section 2.1(a) and Section 2.2.

 

ARTICLE II. 

PURCHASE AND SALE

 

2.1              Closing.

 

(a)               Upon the terms and subject to the conditions set forth herein, the Company agrees to sell in the aggregate ________ shares of Common Stock or Pre-Funded Warrants and Common Warrants exercisable for an aggregate of ________ shares of Common Stock, and each Underwriter agrees to purchase, severally and not jointly, at the Closing, the following securities of the Company;

 

(i)                 the number of shares of Common Stock (the “Closing Shares”) set forth opposite the name of such Underwriter on Schedule I hereof; and

 

(ii)              Common Warrants to purchase up to the number of shares of Common Stock set forth opposite the name of such Underwriter on Schedule I hereof (the “Closing Common Warrants”), which Common Warrants shall have an exercise price of $____, subject to adjustment as provided therein.

 

(iii)            Pre-Funded Warrants to purchase up to the number of shares of Common Stock set forth opposite the name of such Underwriter on Schedule I hereof, which shall have an exercise price equal to $0.0001 (subject to adjustment therein), and shall be exercisable immediately following their issuance and at any time thereafter (the “Closing Pre-Funded Warrants”) and, collectively with the Closing Shares and Closing Common Warrants, the “Closing Securities”);

 

 

 5 

 

 

(b)               The aggregate purchase price for the Closing Securities shall equal the amount set forth opposite the name of such Underwriter on Schedule I hereto (the “Closing Purchase Price”). The combined purchase price for one share of Common Stock and one Common Warrant shall be $____ (the “Combined Purchase Price”) which shall be allocated as $____ per share of Common Stock (the “Share Purchase Price”) and $____ per Common Warrant (the “Warrant Purchase Price”). The combined purchase price for one Pre-Funded Warrant and one Common Warrant, as applicable, shall be $____ which shall be allocated as $____ per Pre-Funded Warrant and $____ per Common Warrant, as applicable; and

 

(c)               On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire transfer, immediately available funds equal to such Underwriter’s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter its respective Closing Securities and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of EGS or such other location as the Company and Representative shall mutually agree. The Public Securities are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus (the “Offering”).

 

2.2              Over-Allotment Option.

 

(a)               For the purposes of covering any over-allotments in connection with the distribution and sale of the Closing Securities, the Representative is hereby granted an option (the “Over-Allotment Option”) to purchase, in the aggregate, up to ____ shares of Common Stock (the “Option Shares”) and/or Warrants to purchase up to ____ shares of Common Stock (the “Option Warrants” and, collectively with the Option Shares, the “Option Securities”) which may be purchased in any combination of Option Shares and/or Option Warrants at the Share Purchase Price and/or Warrant Purchase Price, respectively.

 

(b)               In connection with an exercise of the Over-Allotment Option, (a) the purchase price to be paid for the Option Shares is equal to the product of the Share Purchase Price multiplied by the number of Option Shares to be purchased and (b) the purchase price to be paid for the Option Warrants is equal to the product of the Warrant Purchase Price multiplied by the number of Option Warrants (the aggregate purchase price to be paid on an Option Closing Date, the “Option Closing Purchase Price”).

 

(c)               The Over-Allotment Option granted pursuant to this Section 2.2 may be exercised by the Representative as to all (at any time) or any part (from time to time) of the Option Securities within forty five (45) days after the Execution Date. An Underwriter will not be under any obligation to purchase any Option Securities prior to the exercise of the Over-Allotment Option by the Representative. The Over-Allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic transmission setting forth the number of Option Shares and/or Option Warrants to be purchased and the date and time for delivery of and payment for the Option Securities (each, an “Option Closing Date”), which will not be later than two (2) full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of EGS or at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities does not occur on the Closing Date, each Option Closing Date will be as set forth in the notice. Upon exercise of the Over-Allotment Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will become obligated to purchase, the number of Option Shares and/or Option Warrants specified in such notice. The Representative may cancel the Over-Allotment Option at any time prior to the expiration of the Over-Allotment Option by written notice to the Company.

 

2.3              Deliveries. The Company shall deliver or cause to be delivered to each Underwriter (if applicable) the following:

 

(i)                 At the Closing Date, the Closing Shares and, as to each Option Closing Date, if any, the applicable Option Shares, which shares shall be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;

 

(ii)              At the Closing Date, the Closing Warrants and, as to each Option Closing Date, if any, the applicable Option Warrants, which warrant shall be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;

 

 

 6 

 

 

(iii)            At the Closing Date, a legal opinion of Company Counsel addressed to the Underwriters, including, without limitation, a negative assurance letter, substantially in the form and substance reasonably satisfactory to the Representative and as to the Closing Date and as to each Option Closing Date, if any, a bring-down opinion from Company Counsel in form and substance reasonably satisfactory to the Representative and the favorable opinion of IP Counsel, including, without limitation, a negative assurance letter, addressed to the Underwriters and in form and substance satisfactory to the Representative;

 

(iv)             Contemporaneously herewith, a cold comfort letter, addressed to the Underwriters and in form and substance satisfactory in all respects to the Representative from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as of the Closing Date and each Option Closing Date, if any;

 

(v)               On the Closing Date and on each Option Closing Date, the duly executed and delivered Officer’s Certificate, substantially in form and substance reasonably satisfactory to the Representative;

 

(vi)             On the Closing Date and on each Option Closing Date, the duly executed and delivered Secretary’s Certificate, substantially in form and substance reasonably satisfactory to the Representative; and

 

(vii)          At the Closing Date, the Warrant Agency Agreement duly executed by the parties thereto;

 

(viii)        Contemporaneously herewith, the duly executed and delivered Lock-Up Agreements.

 

2.4              Closing Conditions. The respective obligations of each Underwriter hereunder in connection with the Closing and each Option Closing Date are subject to the following conditions being met:

 

(i)                 the accuracy in all material respects when made and on the date in question (other than representations and warranties of the Company already qualified by materiality, which shall be true and correct in all respects) of the representations and warranties of the Company contained herein (unless as of a specific date therein);

 

(ii)              all obligations, covenants and agreements of the Company required to be performed at or prior to the date in question shall have been performed;

 

(iii)            the delivery by the Company of the items set forth in Section 2.3 of this Agreement;

 

(iv)             the Registration Statement shall be effective on the date of this Agreement and at each of the Closing Date and each Option Closing Date, if any, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or shall be pending or contemplated by the Commission and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative;

 

(v)               by the Execution Date, if required by FINRA, the Underwriters shall have received clearance from FINRA as to the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement;

 

(vi)             the Closing Shares, the Warrant Shares and the Option Shares have been approved for listing on the Trading Market; and

 

(vii)          prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration Statement, Prospectus and the SEC Reports; (ii) no action suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Affiliate of the Company before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial condition or income of the Company, except as set forth in the Registration Statement, Prospectus and the SEC Reports; (iii) no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by the Commission; and (iv) the Registration Statement and the Prospectus and any amendments or supplements thereto and the SEC Reports shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the rules and regulations thereunder and shall conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder, and neither the Registration Statement nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.

 

 

 7 

 

 

ARTICLE III. 

REPRESENTATIONS AND WARRANTIES

 

3.1              Representations and Warranties of the Company. The Company represents and warrants to the Underwriters as of the Execution Date, as of the Closing Date and as of each Option Closing Date, if any, as follows:

 

(a)               Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no Subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

(b)               Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(c)               Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(d)               No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Public Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

 

 8 

 

 

(e)               Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filing with the Commission of the Prospectus and (ii) such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

(f)                Registration Statement. The Company has filed with the Commission the Registration Statement, including any related Prospectus or Prospectuses, for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the Company in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities Act. The Registration Statement has been declared effective by the Commission on the date hereof (the “Effective Date”). The Company has filed with the Commission a Form 8-A (File Number 001-40071) providing for the registration under the Exchange Act of Closing Shares and the Option Shares. The registration of the Closing Shares and the Option Shares under the Exchange Act has been declared effective by the Commission on the date hereof.

 

(g)               Issuance of Securities. The Public Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of Ordinary Shares issuable pursuant to this Agreement and the Warrants. The holder of the Public Securities will not be subject to personal liability by reason of being such holders. The Public Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. All corporate action required to be taken for the authorization, issuance and sale of the Public Securities has been duly and validly taken. The Public Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement.

 

(h)               Capitalization. The capitalization of the Company is as set forth in the SEC Reports. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Public Shares will not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Underwriters). There are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. The authorized shares of the Company conform in all material respects to all statements relating thereto contained in the Registration Statement and the Prospectus. The offers and sales of the Company’s securities were at all relevant times either registered under the Securities Act and the applicable state securities or Blue Sky laws or, based in part on the representations and warranties of the purchasers, exempt from such registration requirements. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Public Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

 

 9 

 

 

(i)                 SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described in the Registration Statement, the Prospectus, the Prospectus Supplement and the SEC Reports conform to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and regulations thereunder to be described in the Registration Statement, the Prospectus, the Prospectus Supplement or the SEC Reports or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Prospectus, the Prospectus Supplement or the SEC Reports, or (ii) is material to the Company’s business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company’s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the best of the Company’s knowledge, any other party is in default thereunder and, to the best of the Company’s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. To the best of the Company’s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.

 

(j)                 Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans and (vi) no officer or director of the Company has resigned from any position with the Company. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Public Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made. Unless otherwise disclosed in an SEC Report filed prior to the date hereof, the Company has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.

 

 

 10 

 

 

(k)               Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(l)                 Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(m)             Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(n)               Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (each, a “Material Permit”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit. The disclosures in the Registration Statement concerning the effects of Federal, State, local and all foreign regulation on the Company’s business as currently contemplated are correct in all material respects.

 

(o)               Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to, or have valid and marketable rights to lease or otherwise use, all real property and all personal property that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens  disclosed in the SEC Reports, (ii) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (iii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made in accordance with GAAP, and the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.

 

 

 11 

 

 

(p)               Intellectual Property. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to do so could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(q)               Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

(r)                Transactions With Affiliates and Employees. Except as set forth in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.

 

(s)                Sarbanes-Oxley; Internal Accounting Controls. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

 

 

 

 12 

 

 

(t)                 Certain Fees. Except as set forth in the Prospectus Supplement, no brokerage or finder’s fees or commissions are or will be payable by the Company, any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. To the Company’s knowledge, there are no other arrangements, agreements or understandings of the Company or, to the Company’s knowledge, any of its stockholders that may affect the Underwriters’ compensation, as defined by FINRA. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii)  any FINRA member participating in the offering as defined in FINRA Rule 5110(j)(15) (a “Participating FINRA Member”); or (iii) any person or entity that has any direct or indirect affiliation or association with any Participating FINRA Member, within the twelve months prior to the Execution Date. None of the net proceeds of the Offering will be paid by the Company to any Participating FINRA Member or its affiliates, except as specifically authorized herein.

 

(u)               Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(v)               Registration Rights. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(w)             Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as disclosed in the SEC Reports , the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees of the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

 

(x)               Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their obligations or exercising their rights under the Transaction Documents.

 

 

 

 

 

 13 

 

 

(y)               Disclosure; 10b-5. The Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any, at the time it became effective, complied in all material respects with the Securities Act and the Exchange Act and the applicable rules and regulations under the Securities Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. The Preliminary Prospectus, Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with the Securities Act and the Exchange Act and the applicable rules and regulations. Each of the Preliminary Prospectus, Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The SEC Reports, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein (with respect to the SEC Reports incorporated by reference in the Preliminary Prospectus, Prospectus or Prospectus Supplement), in light of the circumstances under which they were made not misleading; and any further documents so filed and incorporated by reference in the Preliminary Prospectus, Prospectus or Prospectus Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to be described in the Preliminary Prospectus, Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading.

 

(z)               No Integrated Offering. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.

 

(aa)            Solvency. Except as disclosed in the SEC Reports, based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. The SEC Reports sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

(bb)           Stock Option Plans. Each stock option granted by the Company under the Company’s stock option plan was granted (i) in accordance with the terms of the Company’s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.

 

 

 14 

 

 

(cc)            Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. The term “taxes” mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term “returns” means all returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.

 

(dd)           Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.

 

(ee)            Accountants. To the knowledge and belief of the Company, the Company Auditor (i) is an independent registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report for the fiscal year ending December 31, 2023. The Company Auditor has not, during the periods covered by the financial statements included in the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.

 

(ff)              Reserved.

 

(gg)           Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.

 

(hh)           U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative’s request.

 

(ii)              Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(jj)              Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

 

 15 

 

 

(kk)           D&O Questionnaires. To the Company’s knowledge, all information contained in the questionnaires completed by each of the Company’s directors and officers immediately prior to the Offering as well as in the Lock-Up Agreement provided to the Underwriters is true and correct in all respects and the Company has not become aware of any information which would cause the information disclosed in such questionnaires become inaccurate and incorrect.

 

(ll)              FINRA Affiliation. No officer, director or any beneficial owner of 10% or more of the Company’s unregistered securities has any direct or indirect affiliation or association with any Participating FINRA Member (as determined in accordance with the rules and regulations of FINRA). The Company will advise the Representative and EGS if it learns that any officer, director or owner of 10% or more of the Company’s outstanding shares of Common Stock or Common Stock Equivalents is or becomes an affiliate or associated person of a Participating FINRA Member firm.

 

(mm)      Officers’ Certificate. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative or EGS shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.

 

(nn)           Board of Directors. The Board of Directors is comprised of the persons set in the SEC Reports. The qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder applicable to the Company and the rules of the Trading Market. At least one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and the rules of the Trading Market. In addition, at least a majority of the persons serving on the Board of Directors qualify as “independent” as defined under the rules of the Trading Market.

 

(oo)           Cybersecurity.  (i)(x) To the Company’s knowledge, there has been no security breach or other compromise of or relating to any of the Company’s or any Subsidiary’s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, “IT Systems and Data”) and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.

 

(pp)           Regulation M. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Representative in connection with this Agreement.

 

(qq)           Environmental Laws. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

 

 16 

 

 

ARTICLE IV. 

OTHER AGREEMENTS OF THE PARTIES

 

4.1              Amendments to Registration Statement. The Company has delivered, or will as promptly as practicable deliver, to the Underwriters complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement (without exhibits), the Prospectus and the Prospectus Supplement, as amended or supplemented, in such quantities and at such places as an Underwriter reasonably requests. Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Public Securities other than the Prospectus, the Prospectus Supplement, the Registration Statement, and copies of the documents incorporated by reference therein. The Company shall not file any such amendment or supplement to which the Representative shall reasonably object in writing.

 

4.2              Federal Securities Laws.

 

(a)               Compliance. During the time when a Prospectus is required to be delivered under the Securities Act, the Company will use its best efforts to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange Act and the rules and regulations thereunder, as from time to time in force, so far as necessary to permit the continuance of sales of or dealings in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating to the Securities is required to be delivered under the Securities Act, any event shall have occurred as a result of which, in the opinion of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply with the Securities Act, the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section 4.1 hereof, an appropriate amendment or supplement in accordance with Section 10 of the Securities Act.

 

(b)               Filing of Final Prospectus. The Company will file the Prospectus (in form and substance satisfactory to the Representative) with the Commission pursuant to the requirements of Rule 424.

 

(c)               Exchange Act Registration. For a period of three years from the Execution Date, the Company will use its best efforts to maintain the registration of the Common Stock under the Exchange Act. The Company will not deregister the Common Stock under the Exchange Act without the prior written consent of the Representative.

 

(d)               Free Writing Prospectuses. The Company represents and agrees that it has not made and will not make any offer relating to the Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities Act, without the prior written consent of the Representative. Any such free writing prospectus consented to by the Representative is herein referred to as a Permitted Free Writing Prospectus.” The Company represents that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus” as defined in rule and regulations under the Securities Act, and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission filing where required, legending and record keeping.

 

4.3              Delivery to the Underwriters of Prospectuses. The Company will deliver to the Underwriters, without charge, from time to time during the period when the Prospectus is required to be delivered under the Securities Act or the Exchange Act such number of copies of each Prospectus as the Underwriters may reasonably request and, as soon as the Registration Statement or any amendment or supplement thereto becomes effective, deliver to you two original executed Registration Statements, including exhibits, and all post-effective amendments thereto and copies of all exhibits filed therewith or incorporated therein by reference and all original executed consents of certified experts.

 

 

 

 17 

 

 

4.4              Effectiveness and Events Requiring Notice to the Underwriters. The Company will use its best efforts to cause the Registration Statement to remain effective with a current prospectus until the later of nine (9) months from the Execution Date and the date on which the Warrants are no longer outstanding, and will notify the Underwriters and holders of the Warrants immediately and confirm the notice in writing: (i) of the effectiveness of the Registration Statement and any amendment thereto; (ii) of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii) of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and (vi) of the happening of any event during the period described in this Section 4.4 that, in the judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus untrue or that requires the making of any changes in the Registration Statement or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.

 

4.5              Review of Financial Statements. For a period of five (5) years from the Execution Date, the Company, at its expense, shall cause its regularly engaged independent registered public accountants to review (but not audit) the Company’s financial statements for each of the first three fiscal quarters prior to the announcement of quarterly financial information.

 

4.6              Expenses of the Offering. The Company hereby agrees to pay on each of the Closing Date and each Option Closing Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all filing fees and communication expenses relating to the registration of the Public Securities to be sold in the Offering (including the Option Securities) with the Commission; (b) all FINRA Public Offering Filing System fees associated with the review of the Offering by FINRA; all fees and expenses relating to the listing of such Closing Shares and Option Shares on the Trading Market and such other stock exchanges as the Company and the Representative together determine; (c) all fees, expenses and disbursements relating to the registration or qualification of such Public Securities under the “blue sky” securities laws of such states and other foreign jurisdictions as the Representative may reasonably designate; (d) the costs of all mailing and printing of the underwriting documents (including, without limitation, the Underwriting Agreement, any Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers’ Agreement, Underwriters’ Questionnaire and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the Representative may reasonably deem necessary; (e) the costs and expenses of the Company’s public relations firm; (f) the costs of preparing, printing and delivering the Public Securities; (g) fees and expenses of the Transfer Agent for the Public Securities (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company); (h) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriters; (i) the fees and expenses of the Company’s accountants; (j) the fees and expenses of the Company’s legal counsel and other agents and representatives; and (k) up to $90,000 for the fees and expenses of EGS. The Underwriters may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date, or each Option Closing Date, if any, the expenses set forth herein to be paid by the Company to the Underwriters.

 

4.7              Application of Net Proceeds. The Company will apply the net proceeds from the Offering received by it in a manner consistent with the application described under the caption “Use of Proceeds” in the Prospectus.

 

4.8              Delivery of Earnings Statements to Security Holders. The Company will make generally available to its security holders as soon as practicable, but not later than the first day of the fifteenth full calendar month following the Execution Date, an earnings statement (which need not be certified by independent public or independent certified public accountants unless required by the Securities Act or the Rules and Regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act) covering a period of at least twelve consecutive months beginning after the Execution Date.

 

4.9              Stabilization. Neither the Company, nor, to its knowledge, any of its employees, directors or shareholders (without the consent of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Public Securities.

 

 

 18 

 

 

4.10          Internal Controls. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

4.11          Accountants. The Company shall continue to retain a nationally recognized independent certified public accounting firm for a period of at least three years after the Execution Date. The Underwriters acknowledge that the Company Auditor is acceptable to the Underwriters.

 

4.12          FINRA. The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA) if it is aware that any 10% or greater shareholder of the Company becomes an affiliate or associated person of an Underwriter.

 

4.13          No Fiduciary Duties. The Company acknowledges and agrees that the Underwriters’ responsibility to the Company is solely contractual and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer shall be deemed to be acting in a fiduciary capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions contemplated by this Agreement. Notwithstanding anything in this Agreement to the contrary, the Company acknowledges that the Underwriters may have financial interests in the success of the Offering that are not limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the shares and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any breach or alleged breach of fiduciary duty.

 

4.14          Warrant Shares. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the issuance of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any such exercise shall be issued free of all restrictive legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any holder thereof to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws).

 

4.15          Board Composition and Board Designations. The Company shall ensure that: (i) the qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and with the listing requirements of the Trading Market and (ii) if applicable, at least one member of the Board of Directors qualifies as a “financial expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.

 

4.16          Securities Laws Disclosure; Publicity. At the request of the Representative, by 9:00 a.m. (New York City time) on the date hereof, the Company shall issue a press release disclosing the material terms of the Offering. The Company and the Representative shall consult with each other in issuing any other press releases with respect to the Offering, and neither the Company nor any Underwriter shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of such Underwriter, or without the prior consent of such Underwriter, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. The Company will not issue press releases or engage in any other publicity, without the Representative’s prior written consent, for a period ending at 5:00 p.m. (New York City time) on the first business day following the 45th day following the Closing Date, other than normal and customary releases issued in the ordinary course of the Company’s business.

 

4.17          Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Underwriter of the Securities is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Underwriter of Securities could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities.

 

 

 19 

 

 

4.18          Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Option Shares pursuant to the Over-Allotment Option and Warrant Shares pursuant to any exercise of the Warrants.

 

4.19          Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Closing Shares, Warrant Shares and Option Shares on such Trading Market and promptly secure the listing of all of the Closing Shares, Warrant Shares and Option Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Closing Shares, Warrant Shares and Option Shares, and will take such other action as is necessary to cause all of the Closing Shares, Warrant Shares and Option Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.

 

4.20          Subsequent Equity Sales.

 

(a)               From the date hereof until ninety (90) days following the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.

 

(b)               From the date hereof until one hundred eighty (180) following the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. “Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price. Any Underwriter shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.

 

(c)               Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.

 

4.21          Research Independence. The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  

 

 

 20 

 

 

ARTICLE V. 

DEFAULT BY UNDERWRITERS

  

If on the Closing Date or any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing Securities or Option Securities, as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise than by reason of any default on the part of the Company), the Representative, or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, shall use their reasonable efforts to procure within 36 hours thereafter one or more of the other Underwriters, or any others, to purchase from the Company such amounts as may be agreed upon and upon the terms set forth herein, the Closing Securities or Option Securities, as the case may be, which the defaulting Underwriter or Underwriters failed to purchase. If during such 36 hours the Representative shall not have procured such other Underwriters, or any others, to purchase the Closing Securities or Option Securities, as the case may be, agreed to be purchased by the defaulting Underwriter or Underwriters, then (a) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall occur does not exceed 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in proportion to the respective numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder, to purchase the Closing Securities or Option Securities, as the case may be, which such defaulting Underwriter or Underwriters failed to purchase, or (b) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall occur exceeds 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the Company or the Representative will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the Company except to the extent provided in Article VI hereof. In the event of a default by any Underwriter or Underwriters, as set forth in this Article V, the applicable Closing Date may be postponed for such period, not exceeding seven days, as the Representative, or if the Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes in the Prospectus or in any other documents or arrangements may be effected. The term “Underwriter” includes any person substituted for a defaulting Underwriter. Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.

 

ARTICLE VI. 

INDEMNIFICATION

 

6.1              Indemnification of the Underwriters. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless the Underwriters, and each dealer selected by each Underwriter that participates in the offer and sale of the Securities (each a “Selected Dealer”) and each of their respective directors, officers and employees and each Person, if any, who controls such Underwriter or any Selected Dealer (“Controlling Person”) within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of any action between such Underwriter and the Company or between such Underwriter and any third party or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i) any Preliminary Prospectus, if any, the Registration Statement or the Prospectus (as from time to time each may be amended and supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities, including any “road show” or investor presentations made to investors by the Company (whether in person or electronically); or (iii) any application or other document or written communication (in this Article VI, collectively called “application”) executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof or filed with the Commission, any state securities commission or agency, Trading Market or any securities exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, unless such statement or omission was made in reliance upon and in conformity with written information furnished to the Company with respect to the applicable Underwriter by or on behalf of such Underwriter expressly for use in any Preliminary Prospectus, if any, the Registration Statement or Prospectus, or any amendment or supplement thereto, or in any application, as the case may be. With respect to any untrue statement or omission or alleged untrue statement or omission made in the Preliminary Prospectus, if any, the indemnity agreement contained in this Section 6.1 shall not inure to the benefit of an Underwriter to the extent that any loss, liability, claim, damage or expense of such Underwriter results from the fact that a copy of the Prospectus was not given or sent to the Person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Securities to such Person as required by the Securities Act and the rules and regulations thereunder, and if the untrue statement or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations under this Agreement. The Company agrees promptly to notify each Underwriter of the commencement of any litigation or proceedings against the Company or any of its officers, directors or Controlling Persons in connection with the issue and sale of the Securities or in connection with the Registration Statement or Prospectus.

 

 

 21 

 

 

6.2              Procedure. If any action is brought against an Underwriter, a Selected Dealer or a Controlling Person in respect of which indemnity may be sought against the Company pursuant to Section 6.1, such Underwriter, such Selected Dealer or Controlling Person, as the case may be, shall promptly notify the Company in writing of the institution of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the reasonable approval of such Underwriter or such Selected Dealer, as the case may be) and payment of actual expenses. Such Underwriter, such Selected Dealer or Controlling Person shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter, such Selected Dealer or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have charge of the defense of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from or additional to those available to the Company (in which case the Company shall not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable fees and expenses of not more than one additional firm of attorneys selected by such Underwriter (in addition to local counsel), Selected Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter, Selected Dealer or Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to approve the terms of any settlement of such action which approval shall not be unreasonably withheld.

 

6.3              Indemnification of the Company. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, its directors, officers and employees and agents who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company to such Underwriter, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions made in any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or in any application, in reliance upon, and in strict conformity with, written information furnished to the Company with respect to such Underwriter by or on behalf of such Underwriter expressly for use in such Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or in any such application. In case any action shall be brought against the Company or any other Person so indemnified based on any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or any application, and in respect of which indemnity may be sought against such Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each other Person so indemnified shall have the rights and duties given to such Underwriter by the provisions of this Article VI. Notwithstanding the provisions of this Section 6.3, no Underwriter shall be required to indemnify the Company for any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters' obligations in this Section 6.3 to indemnify the Company are several in proportion to their respective underwriting obligations and not joint.

 

6.4              Contribution.

 

(a)               Contribution Rights. In order to provide for just and equitable contribution under the Securities Act in any case in which (i) any Person entitled to indemnification under this Article VI makes a claim for indemnification pursuant hereto but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article VI provides for indemnification in such case, or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the part of any such Person in circumstances for which indemnification is provided under this Article VI, then, and in each such case, the Company and each Underwriter, severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by said indemnity agreement incurred by the Company and such Underwriter, as incurred, in such proportions that such Underwriter is responsible for that portion represented by the percentage that the underwriting discount appearing on the cover page of the Prospectus bears to the initial offering price appearing thereon and the Company is responsible for the balance; provided, that, no Person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. For purposes of this Section, each director, officer and employee of such Underwriter or the Company, as applicable, and each Person, if any, who controls such Underwriter or the Company, as applicable, within the meaning of Section 15 of the Securities Act shall have the same rights to contribution as such Underwriter or the Company, as applicable. Notwithstanding the provisions of this Section 6.4, no Underwriter shall be required to contribute any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter. The Underwriters' obligations in this Section 6.4 to contribute are several in proportion to their respective underwriting obligations and not joint.

 

 

 22 

 

 

(b)               Contribution Procedure. Within fifteen days after receipt by any party to this Agreement (or its representative) of notice of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party (“contributing party”), notify the contributing party of the commencement thereof, but the failure to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or its representative of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate therein with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution without the written consent of such contributing party. The contribution provisions contained in this Section 6.4 are intended to supersede, to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available.

  

ARTICLE VII.

MISCELLANEOUS

  

7.1              Termination.

 

(a)               Termination Right. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if any domestic or international event or act or occurrence has materially disrupted, or in its opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on any Trading Market shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction, or (iii) if the United States shall have become involved in a new war or an increase in major hostilities, or (iv) if a banking moratorium has been declared by a New York State or federal authority, or (v) if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities markets, or (vi) if the Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in the Representative’s opinion, make it inadvisable to proceed with the delivery of the Securities, or (vii) if the Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii) if the Representative shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the Company, or such adverse material change in general market conditions as in the Representative’s judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Securities or to enforce contracts made by the Underwriters for the sale of the Securities.

 

(b)               Expenses. In the event this Agreement shall be terminated pursuant to Section 7.1(a), within the time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Representative its actual and accountable out of pocket expenses related to the transactions contemplated herein then due and payable, including the fees and disbursements of EGS up to $25,000 (provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of this Agreement).

 

(c)               Indemnification. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Article VI shall not be in any way effected by such election or termination or failure to carry out the terms of this Agreement or any part hereof.

 

7.2              Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules. Notwithstanding anything herein to the contrary, the Engagement Agreement, dated March 10, 2023 (“Engagement Agreement”), by and between the Company and Ladenburg Thalmann & Co. Inc. shall continue to be effective and the terms therein shall continue to survive and be enforceable by the Representative in accordance with its terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail.

 

 

 23 

 

 

7.3              Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

7.4              Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Representative. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

7.5              Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

7.6              Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.

 

7.7              Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Article VI, the prevailing party in such Action or Proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

 

7.8              Survival. The representations and warranties contained herein shall survive the Closing and the Option Closing, if any, and the delivery of the Securities.

 

7.9              Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

 

 24 

 

 

7.10          Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

7.11          Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Underwriters and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

7.12          Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

7.13          Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

7.14          WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY JURY.

  

(Signature Pages Follow)

 

 

 25 

 

 

 

If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in accordance with its terms.

 

Very truly yours,

 

AUDDIA INC.

 

By:                                                         

Name:
Title:

 

Address for Notice:

 

 

Copy to:

 

Accepted on the date first above written. 

LADENBURG THALMANN & CO. INC. 

As the Representative of the several 

Underwriters listed on Schedule I

 

By:                                                                 

Name: 

Title:

 

Address for Notice:

 

640 Fifth Avenue, 4th Floor 

New York, New York 10019 

Attn: General Counsel 

 

Copy to:

 

Ellenoff Grossman & Schole LLP 

1345 Avenue of the Americas 

New York, New York 10105 

E-mail: swilliams@egsllp.com 

Attention: Sarah Williams

 

 

 26 

 

 

SCHEDULE I

 

Schedule of Underwriters

 

 

 

Underwriters Closing Shares Closing Pre-Funded Warrants Closing Warrants Closing Purchase Price
         
         
Total        

 

 

 

 

 

 

 

 

 27 

 

 

  

Schedule II

 

List of Lock-Up Parties

 

 

· Company directors
· Company executive officers
· Company 10% stockholders (Jeff Thraman, Richard Minicozzi)

 

 

 

 

 

 

 

 

 

 

 

 28 

 

EX-4.3 3 auddia_ex0403.htm COMMON STOCK PURCHASE WARRANT

Exhibit 4.3

 

COMMON STOCK PURCHASE WARRANT

 

auddia inc.

 

 

Warrant Shares: _______ Initial Exercise Date: _______, 2023

 

 

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________[1] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Auddia Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.

 

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Underwriting Agreement (the “Underwriting Agreement”), dated __________, 2023, between the Company and Ladenburg Thalmann & Co. Inc.

 

Section 2. Exercise.

 

a)                  Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company or Warrant Agent (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company or Warrant Agent for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company or Warrant Agent shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

 

 

_____________________

[1] Insert the date that is the _____ year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, insert the immediately following Trading Day.

 

 

   

 

 

Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.

 

b)                  Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $_____, subject to adjustment hereunder (the “Exercise Price”).

 

c)                  Cashless Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

 

(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

 

(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

 

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.  The Company agrees not to take any position contrary to this Section 2(c).

 

Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

 

 2 

 

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if the OTCQB Venture Market (“OTCQB”) or the OTCQX Best Market (“OTCQX”) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (“Pink Market”) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).

 

d)                 Mechanics of Exercise.

 

i.            Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

ii.            Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii.            Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

 

 3 

 

 

iv.            Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v.            No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi.            Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii.            Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

 

 

 

 

 4 

 

 

e)Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

 

 

 5 

 

 

Section 3. Certain Adjustments.

 

a)                  Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)                  Reserved.

 

c)                  Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d)                  Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.

 

 

 6 

 

 

e)                  Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.

 

 

 7 

 

 

f)                   Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g)                  Notice to Holder.

 

i.            Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.            Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

h)                  Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.

 

Section 4. Transfer of Warrant.

 

a)                  Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

 

 8 

 

 

b)                  New Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)                  Warrant Register. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5. Miscellaneous.

 

a)                  No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

 

b)                  Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c)                  Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d)                  Authorized Shares.

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

 

 9 

 

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e)                  Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

f)                   Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g)                  Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

 

 10 

 

 

h)                  Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at _________, Attention: ________, email address: _________,, or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

i)                   Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

j)                   Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)                  Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)                   Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.

 

m)               Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n)                  Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

o)                  Warrant Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.

 

 

********************

 

 

(Signature Page Follows)

 

 

 

 

 11 

 

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

 

auddia inc.

 

 

 

By:__________________________________________ 

Name: 

Title: 

 

 

 

 

 

 

 12 

 

 

 

NOTICE OF EXERCISE

 

To: auddia inc.

  

(1)   The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)   Payment shall take the form of (check applicable box):

 

[ ] in lawful money of the United States; or

 

[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3)   Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

  

_______________________________

 

 _______________________________

  

_______________________________

 

 

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________ 

Signature of Authorized Signatory of Investing Entity: _________________________________________________ 

Name of Authorized Signatory: ___________________________________________________________________ 

Title of Authorized Signatory: ____________________________________________________________________ 

Date: ________________________________________________________________________________________ 

 

 

 

 

 13 

 

  

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name: ______________________________________
  (Please Print)
   
Address: ______________________________________

 

 

Phone Number:

 

Email Address:

 

(Please Print)

 

______________________________________

 

______________________________________

 

Dated: _______________ __, ______  
Holder’s Signature:                                               
Holder’s Address:                                                 

 

 

 

 14 

 

EX-4.4 4 auddia_ex0404.htm PRE-FUNDED COMMON STOCK PURCHASE WARRANT

Exhibit 4.4

 

PRE-FUNDED COMMON STOCK PURCHASE WARRANT

 

auddia inc.

 

Warrant Shares: _______ Initial Exercise Date: _______, 2023

 

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Auddia Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.

 

Section 1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Underwriting Agreement (the “Underwriting Agreement”), dated __________, 2023, between the Company and Ladenburg Thalmann & Co. Inc.

 

Section 2. Exercise.

 

a)                  Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.

 

b)                  Exercise Price. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.0001, subject to adjustment hereunder (the “Exercise Price”).]

 

 

   

 

 

c)                  Cashless Exercise. This Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (“Bloomberg”) as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

  

(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

  

(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

  

If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.  The Company agrees not to take any position contrary to this Section 2(c).

 

Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if the OTCQB Venture Market (“OTCQB”) or the OTCQX Best Market (“OTCQX”) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (“Pink Market”) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

 

 2 

 

 

d)Mechanics of Exercise.

 

i.            Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of the Underwriting Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.

 

ii.            Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

 

iii.            Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

 

 

 3 

 

 

iv.            Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

v.            No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

vi.            Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii.            Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

 

 

 

 

 4 

 

 

e)Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

 

 5 

 

 

Section 3. Certain Adjustments.

 

a)                  Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)                  Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

c)                  Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.

 

 

 

 6 

 

 

d)                  Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.

 

e)                  Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

 

 7 

 

 

f)                   Notice to Holder.

 

i.            Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.            Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

 

Section 4. Transfer of Warrant.

 

a)                  Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

b)                  New Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

 

 8 

 

 

c)                  Warrant Register. The Warrant Agent shall register this Warrant, upon records to be maintained by the Warrant Agent for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5. Miscellaneous.

 

a)                  No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

 

b)                  Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

c)                  Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

d)                  Authorized Shares.

 

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

 

 

 9 

 

 

e)                  Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

f)                   Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g)                  Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h)                  Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at _________, Attention: ________, email address: _________,, or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

i)                   Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

 

 10 

 

 

j)                   Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)                  Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)                   Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

m)               Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

 

n)                  Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

o)                  Warrant Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.

 

 

********************

 

(Signature Page Follows)

 

 

 

 11 

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

 

auddia inc.

 

 

 

By:__________________________________________ 

Name: 

Title:

 

 

 

 

 

 

 12 

 

 

 

NOTICE OF EXERCISE

 

 

To: auddia inc.

 

(1)   The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)   Payment shall take the form of (check applicable box):

 

[ ] in lawful money of the United States; or

 

[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

 

(3)   Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

 

The Warrant Shares shall be delivered to the following DWAC Account Number:

  

_______________________________

  

_______________________________

  

_______________________________

 

 

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ________________________________________________________________________ 

Signature of Authorized Signatory of Investing Entity: _________________________________________________ 

Name of Authorized Signatory: ___________________________________________________________________ 

Title of Authorized Signatory: ____________________________________________________________________ 

Date: ________________________________________________________________________________________

 

 

 

 

 13 

 

 

  

EXHIBIT B

 

 

ASSIGNMENT FORM

 

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

Name: ______________________________________
  (Please Print)
   
Address: ______________________________________

 

 

Phone Number:

 

Email Address:

 

(Please Print)

 

______________________________________

 

______________________________________

 

Dated: _______________ __, ______  
Holder’s Signature:                                             
Holder’s Address:                                               

 

 

 

 

 

 

 14 

EX-5.1 5 auddia_ex0501.htm FORM OF OPINION OF CARROLL LEGAL LLC

Exhibit 5.1

 

Carroll Legal LLC

1449 Wynkoop Street

Suite 507

Denver, CO 80202

 

March 28, 2023

 

Auddia Inc.

2100 Central Avenue

Suite 200

Boulder, CO 80301

 

RE: Auddia Inc. Registration Statement on Form S-1

 

Ladies and Gentlemen:

 

We have acted as counsel to Auddia Inc., a Delaware corporation (the “Company”), in connection with its filing with the Securities and Exchange Commission (the “Commission”) of a registration statement on Form S-1 (Registration No. 333-270813, as amended or supplemented from time to time, the “Registration Statement”), relating to the public offering by the Company (the “Offering”) of units (the “Units”) of the Company, with each Unit consisting of: (i) either one share of the Company’s common stock, par value $0.001 per share (the “Common Stock” and such shares, the “Shares”)), or one pre-funded warrant to purchase one share of Common Stock at an exercise price equal to $0.0001 per share of Common Stock (the “Pre-Funded Warrants” and the shares of Common Stock issuable upon exercise thereof, the “Pre-Funded Warrant Shares”) and (ii) one warrant to purchase one and one-half shares of Common Stock (the “Common Warrants” and the shares of Common Stock issuable upon exercise of the Common Warrants, the “Common Warrant Shares”). The Units are to be sold by the Company pursuant to an underwriting agreement (the “Underwriting Agreement”) to be entered into by and between the Company and the underwriters named therein (the “Underwriters”), the form of which has been filed as Exhibit 1.1 to the Registration Statement. As noted in the Registration Statement, for each Pre-Funded Warrant sold, the number of Shares sold will be decreased on a one-for-one basis.

 

The Units, including the Shares, Common Warrants and Pre-Funded Warrants included in the Units, and the Common Warrant Shares and Pre-Funded Warrants Shares are collectively referred to herein as the “Securities.” The term “Shares” includes any additional shares of Common Stock, or shares of Common Stock underlying Common Warrants and Pre-Funded Warrants, issued or issuable pursuant to the exercise of the over-allotment option granted to the Underwriter in the Underwriting Agreement in connection with the offering contemplated by the Registration Statement.

 

This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act of 1933, as amended (the “Securities Act”), and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement other than as expressly stated herein.

 

In connection with this opinion, we have examined the Company’s Restated Certificate of Incorporation and all amendments thereto; the Company’s Restated Bylaws, as currently in effect; the Registration Statement and the exhibits thereto; the prospectus contained in the Registration Statement; the form of Underwriting Agreement; the form of Common Warrant; the form of Warrant Agency Agreement; the form of Pre-Funded Warrant; and such other documents, records, certificates, memoranda and instruments as we have deemed necessary as a basis for this opinion. We have also examined the resolutions of the Board of Directors of the Company authorizing the filing of the Registration Statement by the Company and the issuance of the Securities by the Company (the “Resolutions”).

 

Based upon, subject to and limited by the foregoing, we are of the opinion that following (i) execution and delivery by the Company and the Underwriter of the Underwriting Agreement, (ii) effectiveness of the Registration Statement, and (iii) receipt by the Company of the consideration for the Securities:

 

1.       The Shares will be validly issued, fully paid and non-assessable.

 

2.       The Warrants will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

 

 

 

 1 

 

 

3.       The Pre-Funded Warrants will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.

 

4.       The Common Warrant Shares issuable upon exercise of the Common Warrants and the Pre-Funded Warrant Shares issuable upon exercise of the Pre-Funded Warrants have been duly authorized and, when issued upon exercise of the Common Warrants and the Pre-Funded Warrants upon payment of the applicable exercise price therefor in accordance with the terms thereof, will be validly issued, fully paid and non-assessable

 

Our opinion herein is expressed solely with respect to the General Corporation Law of the State of Delaware. We express no opinion herein as to any other statutes, rules or regulations. We express no opinion herein as to whether the laws of any jurisdiction are applicable to the subject matter hereof. We are not rendering any opinion as to compliance with any federal or other state law, rule or regulation relating to securities, or to the sale or issuance thereof.

 

This opinion letter has been prepared for your use in connection with the Offering. This opinion is expressed as of the date hereof, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable law.

 

We consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the reference to this firm under the caption “Legal Matters” in the prospectus contained therein. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

Very truly yours,

 

Carroll Legal LLC

 

By: /s/ James H. Carroll

Title: Managing Member

 

 

 

 

 

 2 

 

EX-10.10 6 auddia_ex1010.htm FORM OF WARRANT AGENT AGREEMENT

Exhibit 10.10

 

 

 

 

AUDDIA INC.

 

and

 

vStock Transfer LLC, as

Warrant Agent

 

 

 

Warrant Agency Agreement

 

Dated as of ___, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 1 

 

 

WARRANT AGENCY AGREEMENT

 

WARRANT AGENCY AGREEMENT, dated as of ____, 2023 (“Agreement”), between Auddia Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and VStock Transfer LLC (the “Warrant Agent”).

 

W I T N E S S E T H

 

WHEREAS, pursuant to a registered offering by the Company of ___ Units (the “Offering”), with each Unit consisting of one share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (or one pre-funded warrant (the “Pre-Funded Warrants”)) and one warrant (the “Common Warrants”, collectively with the Pre-Funded Warrants, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) at a price of $___ per share (or __% of the price of each share of common stock sold in the Offering); and

 

WHEREAS, the Company granted an over-allotment option to purchase up to 15% of the aggregate number of shares of Common Stock and/or Warrants (the “Over-Allotment Option”) to the Underwriters; and

 

WHEREAS, upon the terms and subject to the conditions hereinafter set forth and pursuant to an effective registration statement on Form S-1, as amended (File No. 333-270813 (the “Registration Statement”), and the terms and conditions of the Warrant Certificate, and the Pre-Funded Warrant Certificate, the Company wishes to issue the Warrants and Pre-Funded Warrants in book entry form entitling the respective holders of the Warrants and Pre-Funded Warrants (the “Holders,” which term shall include a Holder’s transferees, successors and assigns and “Holder” shall include, if the Warrants or the Pre-Funded Warrants are held in “street name,” a Participant (as defined below) or a designee appointed by such Participant); and

 

WHEREAS, the shares of Common Stock (or Pre-Funded Warrants) and Warrants to be issued in connection with the Offering shall be issued separately, but will be purchased together in the Offering; and

 

WHEREAS, the Company wishes the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration, transfer, exchange, exercise and replacement of the Warrants and, in the Warrant Agent’s capacity as the Company’s transfer agent, the delivery of the Warrant Shares.

 

NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:

 

Section 1. Certain Definitions. For purposes of this Agreement, all capitalized terms not herein defined shall have the meanings hereby indicated:

 

(a) “Affiliate” has the meaning ascribed to it in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

(b) “Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which the Nasdaq Stock Market is authorized or required by law or other governmental action to close.

 

(c) “Close of Business” on any given date means 5:00 p.m., New York City time, on such date; provided, however, that if such date is not a Business Day it means 5:00 p.m., New York City time, on the next succeeding Business Day.

 

(d) “Person” means an individual, corporation, association, partnership, limited liability company, joint venture, trust, unincorporated organization, government or political subdivision thereof or governmental agency or other entity.

 

 

 

 2 

 

 

(e) “Warrant Certificate” means a certificate in substantially the form attached as Exhibit 1 or Exhibit 2 hereto, as applicable, representing such number of Warrant Shares as is indicated therein, provided that any reference to the delivery of a Warrant Certificate in this Agreement shall include delivery of a Definitive Certificate or a Global Warrant (each as defined below).

 

(f) Pre-Funded Warrant Certificate ” means a certificate in substantially the form attached as Exhibit 3 or Exhibit 4 hereto, as applicable, representing such number of Pre-Funded Warrant Shares as is indicated therein, provided that any reference to the delivery of a Pre-Funded Warrant Certificate in this Agreement shall include delivery of a Definitive Certificate or a Global Pre-Funded Warrant (each as defined below).

 

All other capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms in the Warrant Certificate and the Pre-Funded Warrant Certificate.

 

Section 2. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company in accordance with the terms and conditions hereof, and the Warrant Agent hereby accepts such appointment.

 

Section 3. Global Warrants.

 

(a) The Warrants and the Pre-Funded Warrants shall be registered securities and shall be evidenced by common global warrants with respect to the Common Warrants (the “Common Global Warrant”) and a pre-funded global warrant with respect to the Pre-Funded Warrants (the “Pre-Funded Global Warrant”), collectively with the Common Global Warrant, the “Global Warrants”), in the form of the Warrant Certificates, which shall be deposited with the Warrant Agent and registered in the name of Cede & Co., a nominee of The Depository Trust Company (the “Depositary”), or as otherwise directed by the Depositary. Ownership of beneficial interests in the Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its nominee for each Global Warrant or (ii) institutions that have accounts with the Depositary (such institution, with respect to a Warrant in its account, a “Participant”).

 

(b) If the Depositary subsequently ceases to make its book-entry settlement system available for the Warrants and the Pre-Funded Warrants, the Company may instruct the Warrant Agent regarding other arrangements for book-entry settlement. In the event that the Warrants and/or the Pre-Funded Warrants are not eligible for, or it is no longer necessary to have the Warrants and Pre-Funded Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver to the Warrant Agent for cancellation each Global Warrant, and the Company shall deliver to each Holder a Definitive Certificate    or a Pre-Funded Warrant Certificate, as the case may be, in the amount of Warrant Certificates and Pre-Funded Warrants certificates listed in the Holders’ name on the books of the Company...

 

(c) A Holder has the right to elect at any time or from time to time a Warrant Exchange (as defined below) pursuant to a Warrant Certificate Request Notice (as defined below). Upon written notice by a Holder to the Company and the Warrant Agent for the exchange of some or all of such Holder’s Global Warrants for a separate certificate in the form attached hereto as Exhibit 1 with respect to a Holder of Common Warrants or Exhibit 2 with respect to a Holder of Pre-Funded Warrants, as applicable (such separate certificate, a “Definitive Certificate”) evidencing the same number of Warrants, which request shall be in the form attached hereto as Exhibit 3 (a “Warrant Certificate Request Notice” and the date of delivery of such Warrant Certificate Request Notice by the Holder, the “Warrant Certificate Request Notice Date” and the surrender by the Holder to the Warrant Agent of a number of Global Warrants for the same number of Warrants evidenced by a Warrant Certificate, a “Warrant Exchange”), the Company and the Warrant Agent shall promptly effect the Warrant Exchange and the Company shall promptly issue and deliver to the Holder a Definitive Certificate for such number of Warrants in the name set forth in the Warrant Certificate Request Notice. Such Definitive Certificate shall be dated the original issue date of the Warrants, shall be manually executed by an authorized signatory of the Company, shall be in the form attached hereto as Exhibit 1 and Exhibit 2, as applicable, and shall be reasonably acceptable in all respects to such Holder. In connection with a Warrant Exchange, the Company agrees to deliver the Definitive Certificate to the Holder within ten (10) Business Days of the Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant Certificate Request Notice (“Warrant Certificate Delivery Date”). If the Company fails for any reason to deliver to the Holder the Definitive Certificate subject to the Warrant Certificate Request Notice by the Warrant Certificate Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by such Definitive Certificate (based on the VWAP (as defined in the Warrants) of the Common Stock on the Warrant Certificate Request Notice Date), $10 per Business Day for each Business Day after such Warrant Certificate Delivery Date until such Definitive Certificate is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange. The Company covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the Holder shall be deemed to be the holder of the Definitive Certificate and, notwithstanding anything to the contrary set forth herein, the Definitive Certificate shall be deemed for all purposes to contain all of the terms and conditions of the Warrants evidenced by such Warrant Certificate and the terms of this Agreement, other than Sections 3(c), 3(d) and 9 herein, shall not apply to the Warrants evidenced by the Definitive Certificate. Notwithstanding anything herein to the contrary, the Company shall act as warrant agent with respect to any Definitive Certificate requested and issued pursuant to this section. Notwithstanding anything to the contrary contained in this Agreement, in the event of inconsistency between any provision in this Agreement and any provision in a Definitive Certificate, as it may from time to time be amended, the terms of such Definitive Certificate shall control.

 

 

 

 3 

 

 

(d) A Holder of a Definitive Certificate (pursuant to a Warrant Exchange or otherwise) has the right to elect at any time or from time to time a Global Warrants Exchange (as defined below) pursuant to a Global Warrants Request Notice (as defined below). Upon written notice by a Holder to the Company for the exchange of some or all of such Holder’s Warrants evidenced by a Definitive Certificate for a beneficial interest in Global Warrants held in book-entry form through the Depositary evidencing the same number of Warrants, which request shall be in the form attached hereto as Exhibit 4 (a “Global Warrants Request Notice” and the date of delivery of such Global Warrants Request Notice by the Holder, the “Global Warrants Request Notice Date” and the surrender upon delivery by the Holder of the Warrants evidenced by Definitive Certificates for the same number of Warrants evidenced by a beneficial interest in Global Warrants held in book-entry form through the Depositary, a “Global Warrants Exchange”), the Company shall promptly effect the Global Warrants Exchange and shall promptly direct the Warrant Agent to issue and deliver to the Holder Global Warrants for such number of Warrants in the Global Warrants Request Notice, which beneficial interest in such Global Warrants shall be delivered by the Depositary’s Deposit or Withdrawal at Custodian system to the Holder pursuant to the instructions in the Global Warrants Request Notice. In connection with a Global Warrants Exchange, the Company shall direct the Warrant Agent to deliver the beneficial interest in such Global Warrants to the Holder within ten (10) Business Days of the Global Warrants Request Notice pursuant to the delivery instructions in the Global Warrant Request Notice (“Global Warrants Delivery Date”). If the Company fails for any reason to deliver to the Holder Global Warrants subject to the Global Warrants Request Notice by the Global Warrants Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by such Global Warrants (based on the VWAP (as defined in the Warrants) of the Common Stock on the Global Warrants Request Notice Date), $10 per Business Day (increasing to $20 per Business Day on the fifth Business Day after such liquidated damages begin to accrue) for each Business Day after such Global Warrants Delivery Date until such Global Warrants are delivered or, prior to delivery of such Global Warrants, the Holder rescinds such Global Warrants Exchange. The Company covenants and agrees that, upon the date of delivery of the Global Warrants Request Notice, the Holder shall be deemed to be the beneficial holder of such Global Warrants.

 

Section 4. Form of Warrant Certificates. The Warrant Certificate, together with the form of election to purchase Common Stock (“Notice of Exercise”) and the form of assignment to be printed on the reverse thereof, shall be in the form of Exhibit 1 or Exhibit 2 hereto, as applicable.

 

Section 5. Countersignature and Registration. The Global Warrant shall be executed on behalf of the Company by its Chief Executive Officer, Chief Financial Officer or Vice President, by facsimile signature, and have affixed thereto the Company’s seal or a facsimile thereof which shall be attested by the Secretary or an Assistant Secretary of the Company, by facsimile signature. The Global Warrant shall be countersigned by the Warrant Agent by facsimile signature and shall not be valid for any purpose unless so countersigned. In case any officer of the Company who shall have signed any of the Global Warrant shall cease to be such officer of the Company before countersignature by the Warrant Agent and issuance and delivery by the Company, such Global Warrant, nevertheless, may be countersigned by the Warrant Agent, issued and delivered with the same force and effect as though the person who signed such Global Warrant had not ceased to be such officer of the Company; and any Global Warrant may be signed on behalf of the Company by any person who, at the actual date of the execution of such Global Warrant, shall be a proper officer of the Company to sign such Global Warrant, although at the date of the execution of this Warrant Agreement any such person was not such an officer.

 

The Warrant Agent will keep or cause to be kept, at one of its offices, or at the office of one of its agents, books for registration and transfer of the Global Warrants issued hereunder. Such books shall show the names and addresses of the respective Holders of the Global Warrant, the number of warrants evidenced on the face of each of such Global Warrant and the date of each of such Global Warrant. The Warrant Agent will create a special account for the issuance of Global Warrants. The Company will keep or cause to be kept at one of its offices, books for the registration and transfer of any Definitive Certificates issued hereunder and the Warrant Agent shall not have any obligation to keep books and records with respect to any Definitive Warrants. Such Company books shall show the names and addresses of the respective Holders of the Definitive Certificates, the number of warrants evidenced on the face of each such Definitive Certificate and the date of each such Definitive Certificate.

 

 

 

 4 

 

 

Section 6. Transfer, Split Up, Combination and Exchange of Warrant Certificates; Mutilated, Destroyed, Lost or Stolen Warrant Certificates. With respect to the Global Warrants, subject to the provisions of the Definitive Warrant Certificate and the last sentence of this first paragraph of Section 6 and subject to applicable law, rules or regulations, or any “stop transfer” instructions the Company may give to the Warrant Agent, at any time after the closing date of the Offering, and at or prior to the Close of Business on the Termination Date (as such term is defined in the Definitive Warrant Certificate. Any requested transfer of Warrants, whether in book-entry form or certificate form, shall be accompanied by reasonable evidence of authority of the party making such request that may be required by the Warrant Agent. Thereupon the Warrant Agent shall, subject to the last sentence of this first paragraph of Section 6, countersign and deliver to the Person entitled thereto a Global Warrant or Global Warrants, as the case may be, as so requested. The Company may require payment from the Holder of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination or exchange of Global Warrants. The Company shall compensate the Warrant Agent per the fee schedule mutually agreed upon by the parties hereto and provided separately on the date hereof.

 

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of a Warrant Certificate, which evidence shall include an affidavit of loss, or in the case of mutilated certificates, the certificate or portion thereof remaining, and, in case of loss, theft or destruction, of indemnity in customary form and amount (but, with respect to any Definitive Certificates, shall not include the posting of any bond by the Holder), and satisfaction of any other reasonable requirements established by Section 8-405 of the Uniform Commercial Code as in effect in the State of Delaware, and reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender to the Company and cancellation of the Warrant Certificate if mutilated, the Company will make and deliver a new Warrant Certificate of like tenor to the Holder in lieu of the Warrant Certificate so lost, stolen, destroyed or mutilated.

 

Section 7. Exercise of Warrants; Exercise Price; Termination Date.

 

(a) The Warrants shall be exercisable commencing on the Initial Exercise Date. The Warrants shall cease to be exercisable and shall terminate and become void as set forth in the Warrant Certificate. Subject to the foregoing and to Section 7(b) below, the Holder of a Warrant may exercise the Warrant in whole or in part pursuant to Section 2 of the Warrant Certificate and payment of the Exercise Price, which may be made, at the option of the Holder, by wire transfer or by certified or official bank check in United States dollars, to the Warrant Agent, with respect to exercise of a Global Warrant, at the principal office of the Warrant Agent or to the office of one of its agents as may be designated by the Warrant Agent from time to time. In the case of the Holder of a Global Warrant, the Holder shall deliver the executed Notice of Exercise and the payment of the Exercise Price as described herein. Notwithstanding any other provision in this Agreement, a holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant held in book-entry form through the Depositary (or another established clearing corporation performing similar functions), shall effect exercises by delivering to the Depositary (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by the Depositary (or such other clearing corporation, as applicable). The Company acknowledges that the bank accounts maintained by the Warrant Agent in connection with the services provided under this Agreement will be in its name and that the Warrant Agent may receive investment earnings in connection with the investment at Warrant Agent risk and for its benefit of funds held in those accounts from time to time. Neither the Company nor the Holders will receive interest on any deposits or Exercise Price. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Company hereby acknowledges and agrees that, with respect to a holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant held in book-entry form through the Depositary (or another established clearing corporation performing similar functions), upon delivery of irrevocable instructions to such holder’s Participant to exercise such warrants, that solely for purposes of Regulation SHO that such holder shall be deemed to have exercised such warrants.

 

 

 

 5 

 

 

(b) Upon receipt of a Notice of Exercise for a Cashless Exercise the Company will promptly calculate and transmit to the Warrant Agent the number of Warrant Shares issuable in connection with such Cashless Exercise and deliver a copy of the Notice of Exercise to the Warrant Agent, which shall issue such number of Warrant Shares in connection with such Cashless Exercise.

 

(c) Upon the exercise of the Warrant Certificate pursuant to the terms of Section 2 of the Warrant Certificate, the Warrant Agent, with respect to exercise of a Global Warrant, shall cause the Warrant Shares underlying such Global Warrant to be delivered to or upon the order of the Holder of such Global Warrant, registered in such name or names as may be designated by such Holder, no later than the Warrant Share Delivery Date (as such term is defined in the Warrant Certificate). If the Company is then a participant in the DWAC system of the Depositary and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant is being exercised via Cashless Exercise, then the certificates for Warrant Shares shall be transmitted by the Warrant Agent to the Holder by crediting the account of the Holder’s broker with the Depositary through its DWAC system. For the avoidance of doubt, if the Company becomes obligated to pay any amounts to any Holders pursuant to Section 2(d)(i) or 2(d)(iv) of the Warrant Certificate, such obligation shall be solely that of the Company and not that of the Warrant Agent. Notwithstanding anything else to the contrary in this Agreement, except in the case of a Cashless Exercise, if any Holder fails to duly deliver payment to the Warrant Agent of an amount equal to the aggregate Exercise Price of the Warrant Shares to be purchased upon exercise of such Holder’s Warrant as set forth in Section 7(a) hereof by the Warrant Share Delivery Date, the Warrant Agent will not obligated to deliver such Warrant Shares (via DWAC or otherwise) until following receipt of such payment, and the applicable Warrant Share Delivery Date shall be deemed extended by one day for each day (or part thereof) until such payment is delivered to the Warrant Agent.

 

(d) The Warrant Agent shall deposit all funds received by it in payment of the Exercise Price for all Warrants in the account of the Company maintained with the Warrant Agent for such purpose (or to such other account as directed by the Company in writing) and shall advise the Company via email at the end of each day on which notices of exercise are received or funds for the exercise of any Warrant are received of the amount so deposited to its account.

 

Section 8. Cancellation and Destruction of Warrant Certificates. All Warrant Certificates surrendered to the Company for the purpose of exercise, transfer, split up, combination or exchange shall be canceled by it, and no Warrant Certificate shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement.

 

Section 9. Certain Representations; Reservation and Availability of Shares of Common Stock or Cash.

 

(a) This Agreement has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by the Warrant Agent, constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance with its terms, and the Warrants have been duly authorized, executed and issued by the Company and, assuming due authentication thereof by the Warrant Agent pursuant hereto and payment therefor by the Holders as provided in the Registration Statement, constitute valid and legally binding obligations of the Company enforceable against the Company in accordance with their terms and entitled to the benefits hereof; in each case except as enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally or by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).

 

(b) As of the date hereof, the authorized capital stock of the Company consists of (i) ([ ],000,000) shares of common stock, of which approximately [ ] shares of Common Stock are issued and outstanding as of December 31, 2022, and [ ] shares of Common Stock are reserved for issuance upon exercise of the Warrants, and (ii) [ ] million ([ ],000,000) shares of preferred stock, par value $0.0001 per share, of which no shares are issued and outstanding. Except as disclosed in the Registration Statement, there are no other outstanding obligations, warrants, options or other rights to subscribe for or purchase from the Company any class of capital stock of the Company.

 

 

 

 

 6 

 

 

(c) The Company covenants and agrees that it will cause to be reserved and kept available out of its authorized and unissued shares of Common Stock or its authorized and issued shares of Common Stock held in its treasury, free from preemptive rights, the number of shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants.

 

(d) The Warrant Agent will create a special account for the issuance of Common Stock upon the exercise of Warrants.

 

(e) The Company further covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges which may be payable in respect of the original issuance or delivery of the Warrant Certificates or certificates evidencing Common Stock upon exercise of the Warrants. The Company shall not, however, be required to pay any tax or governmental charge which may be payable in respect of any transfer involved in the transfer or delivery of Warrant Certificates or the issuance or delivery of certificates for Common Stock in a name other than that of the Holder of the Warrant Certificate evidencing Warrants surrendered for exercise or to issue or deliver any certificate for shares of Common Stock upon the exercise of any Warrants until any such tax or governmental charge shall have been paid (any such tax or governmental charge being payable by the Holder of such Warrant Certificate at the time of surrender) or until it has been established to the Company’s reasonable satisfaction that no such tax or governmental charge is due.

 

Section 10. Common Stock Record Date. Each Person in whose name any certificate for shares of Common Stock is issued (or to whose broker’s account is credited shares of Common Stock through the DWAC system) upon the exercise of Warrants shall for all purposes be deemed to have become the holder of record for the Common Stock represented thereby on, and such certificate shall be dated, the date on which submission of the Notice of Exercise was made, provided that the Warrant Certificate evidencing such Warrant is duly surrendered (but only if required herein) and payment of the Exercise Price (and any applicable transfer taxes) is received on or prior to the Warrant Share Delivery Date; provided, however, that if the date of submission of the Notice of Exercise is a date upon which the Common Stock transfer books of the Company are closed, such Person shall be deemed to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding day on which the Common Stock transfer books of the Company are open.

 

Section 11. Adjustment of Exercise Price, Number of Shares of Common Stock or Number of the Company Warrants. The Exercise Price, the number of shares covered by each Warrant and the number of Warrants outstanding are subject to adjustment from time to time as provided in Section 3 of the Warrant Certificate. In the event that at any time, as a result of an adjustment made pursuant to Section 3 of the Warrant Certificate, the Holder of any Warrant thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than shares of Common Stock, thereafter the number of such other shares so receivable upon exercise of any Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the shares contained in Section 3 of the Warrant Certificate and the provisions of Sections 7, 11 and 12 of this Agreement with respect to the shares of Common Stock shall apply on like terms to any such other shares. All Warrants originally issued by the Company subsequent to any adjustment made to the Exercise Price pursuant to the Warrant Certificate shall evidence the right to purchase, at the adjusted Exercise Price, the number of shares of Common Stock purchasable from time to time hereunder upon exercise of the Warrants, all subject to further adjustment as provided herein.

 

Section 12. Certification of Adjusted Exercise Price or Number of Shares of Common Stock. Whenever the Exercise Price or the number of shares of Common Stock issuable upon the exercise of each Warrant is adjusted as provided in Section 11 or 13, the Company shall (a) promptly prepare a certificate setting forth the Exercise Price of each Warrant as so adjusted, and a brief statement of the facts accounting for such adjustment, (b) promptly file with the Warrant Agent and with each transfer agent for the Common Stock a copy of such certificate and (c) instruct the Warrant Agent to send a brief summary thereof to each Holder of a Warrant Certificate.

 

Section 13. Fractional Shares of Common Stock.

 

(a) The Company shall not issue fractions of Warrants or distribute Warrant Certificates which evidence fractional Warrants. Whenever any fractional Warrant would otherwise be required to be issued or distributed, the actual issuance or distribution shall reflect a rounding of such fraction to the nearest whole Warrant (rounded down).

 

 

 

 7 

 

 

(b) The Company shall not issue fractions of shares of Common Stock upon exercise of Warrants or distribute stock certificates which evidence fractional shares of Common Stock. Whenever any fraction of a share of Common Stock would otherwise be required to be issued or distributed, the actual issuance or distribution in respect thereof shall be made in accordance with Section 2(d)(v) of the Warrant Certificate.

 

Section 14. Conditions of the Warrant Agent’s Obligations. The Warrant Agent accepts its obligations herein set forth upon the terms and conditions hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the Holders from time to time of the Warrant Certificates shall be subject:

 

(a)Compensation and Indemnification. The Company agrees promptly to pay the Warrant Agent the compensation detailed on Exhibit 4 hereto for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable counsel fees) incurred without gross negligence or willful misconduct finally adjudicated to have been directly caused by the Warrant Agent in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless against, any loss, liability or expense incurred without gross negligence, or willful misconduct on the part of the Warrant Agent, finally adjudicated to have been directly caused by Warrant Agent hereunder, including the reasonable costs and expenses of defending against any claim of such liability. The Warrant Agent shall be under no obligation to institute or defend any action, suit, or legal proceeding in connection herewith or to take any other action likely to involve the Warrant Agent in expense, unless first indemnified to the Warrant Agent’s satisfaction. The indemnities provided by this paragraph shall survive the resignation or discharge of the Warrant Agent or the termination of this Agreement. Anything in this Agreement to the contrary notwithstanding, in no event shall the Warrant Agent be liable under or in connection with the Agreement for indirect, special, incidental, punitive or consequential losses or damages of any kind whatsoever, including but not limited to lost profits, whether or not foreseeable, even if the Warrant Agent has been advised of the possibility thereof and regardless of the form of action in which such damages are sought, and the Warrant Agent’s aggregate liability to the Company, or any of the Company’s representatives or agents, under this Section 14(a) or under any other term or provision of this Agreement, whether in contract, tort, or otherwise, is expressly limited to, and shall not exceed in any circumstances, one (1) year’s fees received by the Warrant Agent as fees and charges under this Agreement, but not including reimbursable expenses previously reimbursed to the Warrant Agent by the Company hereunder.

 

(b)Agent for the Company. In acting under this Warrant Agreement and in connection with the Warrant Certificates, the Warrant Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with any of the Holders of Warrant Certificates or beneficial owners of Warrants.

 

(c)Counsel. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and the written advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel.

 

(d)Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or omitted by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.

 

(e)Certain Transactions. The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with the Company and may act on, or as depositary, trustee or agent for, any committee or body of Holders of Warrant Securities or other obligations of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as trustee under any indenture to which the Company is a party.

 

(f)No Liability for Interest. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for interest on any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.

 

 

 

 8 

 

 

(g)No Liability for Invalidity. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement or the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon).

 

(h)No Responsibility for Representations. The Warrant Agent shall not be responsible for any of the recitals or representations herein or in the Warrant Certificate (except as to the Warrant Agent’s countersignature thereon), all of which are made solely by the Company.

 

(i)No Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which may tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant Certificates authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by the Company of the proceeds of the Warrant Certificate. The Warrant Agent shall have no duty or responsibility in case of any default by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the receipt of any written demand from a Holder of a Warrant Certificate with respect to such default, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law.

 

Section 15. Purchase or Consolidation or Change of Name of Warrant Agent. Any corporation into which the Warrant Agent or any successor Warrant Agent may be merged or with which it may be consolidated, or any corporation resulting from any merger or consolidation to which the Warrant Agent or any successor Warrant Agent shall be party, or any corporation succeeding to the corporate trust business of the Warrant Agent or any successor Warrant Agent, shall be the successor to the Warrant Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto, provided that such corporation would be eligible for appointment as a successor Warrant Agent under the provisions of Section 17. In case at the time such successor Warrant Agent shall succeed to the agency created by this Agreement any of the Warrant Certificates shall have been countersigned but not delivered, any such successor Warrant Agent may adopt the countersignature of the predecessor Warrant Agent and deliver such Warrant Certificates so countersigned; and in case at that time any of the Warrant Certificates shall not have been countersigned, any successor Warrant Agent may countersign such Warrant Certificates either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all such cases such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.

 

In case at any time the name of the Warrant Agent shall be changed and at such time any of the Warrant Certificates shall have been countersigned but not delivered, the Warrant Agent may adopt the countersignature under its prior name and deliver such Warrant Certificates so countersigned; and in case at that time any of the Warrant Certificates shall not have been countersigned, the Warrant Agent may countersign such Warrant Certificates either in its prior name or in its changed name; and in all such cases such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.

 

Section 16. Duties of Warrant Agent. The Warrant Agent undertakes the duties and obligations imposed by this Agreement upon the following terms and conditions, by all of which the Company, by its acceptance hereof, shall be bound:

 

(a) The Warrant Agent may consult with legal counsel reasonably acceptable to the Company (who may be legal counsel for the Company), and the opinion of such counsel shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in good faith and in accordance with such opinion.

 

(b) Whenever in the performance of its duties under this Agreement the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by the Chief Executive Officer, Chief Financial Officer or Vice President of the Company; and such certificate shall be full authentication to the Warrant Agent for any action taken or suffered in good faith by it under the provisions of this Agreement in reliance upon such certificate.

 

 

 

 9 

 

 

(c) Subject to the limitation set forth in Section 14, the Warrant Agent shall be liable hereunder only for its own gross negligence or willful misconduct, or for a breach by it of this Agreement.

 

(d) The Warrant Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Warrant Certificate (except its countersignature thereof) by the Company or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only.

 

(e) The Warrant Agent shall not be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution hereof by the Warrant Agent) or in respect of the validity or execution of any Warrant Certificate (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant Certificate; nor shall it be responsible for the adjustment of the Exercise Price or the making of any change in the number of shares of Common Stock required under the provisions of Section 11 or 13 or responsible for the manner, method or amount of any such change or the ascertaining of the existence of facts that would require any such adjustment or change (except with respect to the exercise of Warrants evidenced by the Warrant Certificates after actual notice of any adjustment of the Exercise Price); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant Certificate or as to whether any shares of Common Stock will, when issued, be duly authorized, validly issued, fully paid and nonassessable.

 

(f) Each party hereto agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances as may reasonably be required by the other party hereto for the carrying out or performing by any party of the provisions of this Agreement.

 

(g) The Warrant Agent is hereby authorized to accept instructions with respect to the performance of its duties hereunder from the Chief Executive Officer, Chief Financial Officer or Vice President of the Company, and to apply to such officers for advice or instructions in connection with its duties, and it shall not be liable and shall be indemnified and held harmless for any action taken or suffered to be taken by it in good faith in accordance with instructions of any such officer, provided Warrant Agent carries out such instructions without gross negligence or willful misconduct.

 

(h) The Warrant Agent and any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Warrants or other securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not Warrant Agent under this Agreement. Nothing herein shall preclude the Warrant Agent from acting in any other capacity for the Company or for any other legal entity.

 

(i) The Warrant Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorney or agents or for any loss to the Company resulting from any such act, default, neglect or misconduct, provided reasonable care was exercised in the selection and continued employment thereof.

 

 

 

 10 

 

 

Section 17. Change of Warrant Agent. The Warrant Agent may resign and be discharged from its duties under this Agreement upon 30 days’ notice in writing sent to the Company and to each transfer agent of the Common Stock, and to the Holders of the Warrant Certificates. The Company may remove the Warrant Agent or any successor Warrant Agent upon 30 days’ notice in writing, sent to the Warrant Agent or successor Warrant Agent, as the case may be, and to each transfer agent of the Common Stock, and to the Holders of the Warrant Certificates. If the Warrant Agent shall resign or be removed or shall otherwise become incapable of acting, the Company shall appoint a successor to the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after such removal or after it has been notified in writing of such resignation or incapacity by the resigning or incapacitated Warrant Agent or by the Holder of a Warrant Certificate (who shall, with such notice, submit his Warrant Certificate for inspection by the Company), then the Holder of any Warrant Certificate may apply to any court of competent jurisdiction for the appointment of a new Warrant Agent, provided that, for purposes of this Agreement, the Company shall be deemed to be the Warrant Agent until a new warrant agent is appointed. Any successor Warrant Agent, whether appointed by the Company or by such a court, shall be a corporation organized and doing business under the laws of the United States or of a state thereof, in good standing, which is authorized under such laws to exercise corporate trust powers and is subject to supervision or examination by federal or state authority and which has at the time of its appointment as Warrant Agent a combined capital and surplus of at least $50,000,000. After appointment, the successor Warrant Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant Agent without further act or deed; but the predecessor Warrant Agent shall deliver and transfer to the successor Warrant Agent any property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose. Not later than the effective date of any such appointment, the Company shall file notice thereof in writing with the predecessor Warrant Agent and each transfer agent of the Common Stock, and mail a notice thereof in writing to the Holders of the Warrant Certificates. However, failure to give any notice provided for in this Section 17, or any defect therein, shall not affect the legality or validity of the resignation or removal of the Warrant Agent or the appointment of the successor Warrant Agent, as the case may be.

 

Section 18. Issuance of New Warrant Certificates. Notwithstanding any of the provisions of this Agreement or of the Warrants to the contrary, the Company may, at its option, issue new Warrant Certificates evidencing Warrants in such form as may be approved by its Board of Directors to reflect any adjustment or change in the Exercise Price per share and the number or kind or class of shares of stock or other securities or property purchasable under the several Warrant Certificates made in accordance with the provisions of this Agreement.

 

Section 19. Notices. Notices or demands authorized by this Agreement to be given or made (i) by the Warrant Agent or by the Holder of any Warrant Certificate to or on the Company, (ii) subject to the provisions of Section 17, by the Company or by the Holder of any Warrant Certificate to or on the Warrant Agent or (iii) by the Company or the Warrant Agent to the Holder of any Warrant Certificate shall be deemed given (a) on the date delivered, if delivered personally, (b) on the first Business Day following the deposit thereof with Federal Express or another recognized overnight courier, if sent by Federal Express or another recognized overnight courier, (c) on the fourth Business Day following the mailing thereof with postage prepaid, if mailed by registered or certified mail (return receipt requested), and (d) the time of transmission, if such notice or communication is delivered via facsimile or email attachment at or prior to 5:30 p.m. (New York City time) on a Business Day and (e) the next Business Day after the time of transmission, if such notice or communication is delivered via facsimile or email attachment on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, in each case to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):

 

(a)If to the Company, to:

 

[____________]

[____________]

[____________]

 

 

(b)If to the Warrant Agent, to:

 

[____________]

[____________]

[____________]

 

 

 

 11 

 

 

For any notice delivered by email to be deemed given or made, such notice must be followed by notice sent by overnight courier service to be delivered on the next business day following such email, unless the recipient of such email has acknowledged via return email receipt of such email.

 

(c) If to the Holder of any Warrant Certificate to the address of such Holder as shown on the registry books of the Company. Any notice required to be delivered by the Company to the Holder of any Warrant may be given by the Warrant Agent on behalf of the Company. Notwithstanding any other provision of this Agreement, where this Agreement provides for notice of any event to a Holder of any Warrant, such notice shall be sufficiently given if given to the Depositary (or its designee) pursuant to the procedures of the Depositary or its designee.

 

Section 20. Supplements and Amendments.

 

(a) The Company and the Warrant Agent may from time to time supplement or amend this Agreement without the approval of any Holders of Global Warrants in order to add to the covenants and agreements of the Company for the benefit of the Holders of the Global Warrants or to surrender any rights or power reserved to or conferred upon the Company in this Agreement, provided that such addition or surrender shall not adversely affect the interests of the Holders of the Global Warrants or Warrant Certificates in any material respect.

 

(b) In addition to the foregoing, with the consent of Holders of Warrants entitled, upon exercise thereof, to receive not less than a majority of the shares of Common Stock issuable thereunder, the Company and the Warrant Agent may modify this Agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Warrant Agreement or modifying in any manner the rights of the Holders of the Global Warrants; provided, however, that no modification of the terms (including but not limited to the adjustments described in Section 11) upon which the Warrants are exercisable or the rights of holders of Warrants to receive liquidated damages or other payments in cash from the Company or reducing the percentage required for consent to modification of this Agreement may be made without the consent of the Holder of each outstanding Warrant Certificate affected thereby; provided further, however, that no amendment hereunder shall affect any terms of any Warrant Certificate issued in a Warrant Exchange. As a condition precedent to the Warrant Agent’s execution of any amendment, the Company shall deliver to the Warrant Agent a certificate from a duly authorized officer of the Company that states that the proposed amendment complies with the terms of this Section 20.

 

Section 21. Successors. All covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns hereunder.

 

Section 22. Benefits of this Agreement. Nothing in this Agreement shall be construed to give any Person other than the Company, the Holders of Warrant Certificates and the Warrant Agent any legal or equitable right, remedy or claim under this Agreement. This Agreement shall be for the sole and exclusive benefit of the Company, the Warrant Agent and the Holders of the Warrant Certificates. For the avoidance of doubt, and notwithstanding anything to the contrary contained herein, to the extent any provision of a Warrant Certificate conflicts with any provision of this Agreement, the provisions of the Warrant Certificate shall govern and be controlling.

 

Section 23. Governing Law. This Agreement and each Warrant Certificate and Global Warrant issued hereunder shall be governed by, and construed in accordance with, the laws of the State of New York, without giving effect to the conflicts of law principles thereof.

 

Section 24. Counterparts. This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

Section 25. Captions. The captions of the sections of this Agreement have been inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof.

 

Section 26. Information. The Company agrees to promptly provide to the Holders of the Warrants any information it provides to the holders of the Common Stock, except to the extent any such information is publicly available on the EDGAR system (or any successor thereof) of the Securities and Exchange Commission.

 

 

 

 

 

 12 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

  AUDDIA INC.
   
  By:
  Name:
  Title:
   
   
  VSTOCK TRANSFER LLC
   
  By:
  Name:
  Title:
   
   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 13 

 

 

Exhibit 1

 

Form of Common Warrant Certificate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 14 

 

 

Exhibit 2

 

Form of Pre-Funded Warrant Certificate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 15 
 

 

Exhibit 3

Form of Warrant Certificate Request Notice

 

WARRANT CERTIFICATE REQUEST NOTICE

 

To: VStock Transfer LLC, as Warrant Agent for Auddia Inc. (the “Company”)

 

The undersigned Holder of Common Stock Purchase Warrants (“Warrants”) in the form of Global Warrants issued by the Company hereby elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:

 

1.Name of Holder of Warrants in form of Global Warrants: _____________________________

 

2.Name of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants): ________________________________

 

3.Number of Warrants in name of Holder in form of Global Warrants: ___________________

 

4.Number of Warrants for which Warrant Certificate shall be issued: __________________

 

5.Number of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate, if any: ___________

 

6.Warrant Certificate shall be delivered to the following address:

 

______________________________

 

______________________________

 

______________________________

 

______________________________

 

The undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant Certificate, the Holder is deemed to have surrendered the number of Warrants in form of Global Warrants in the name of the Holder equal to the number of Warrants evidenced by the Warrant Certificate.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ____________________________________________________

 

Signature of Authorized Signatory of Investing Entity: ______________________________

 

Name of Authorized Signatory: ________________________________________________

 

Title of Authorized Signatory: _________________________________________________

 

Date: _______________________________________________________________

 

 

 

 16 

 

 

Exhibit 4

Form of Global Warrant Request Notice

 

GLOBAL WARRANT REQUEST NOTICE

 

To: VStock Transfer LLC, as Warrant Agent for Auddia Inc. (the “Company”)

 

The undersigned Holder of Common Stock Purchase Warrants (“Warrants”) in the form of Warrants Certificates issued by the Company hereby elects to receive a Global Warrant evidencing the Warrants held by the Holder as specified below:

 

1.Name of Holder of Warrants in form of Warrant Certificates: _____________________________

 

2.Name of Holder in Global Warrant (if different from name of Holder of Warrants in form of Warrant Certificates): ________________________________

 

3.Number of Warrants in name of Holder in form of Warrant Certificates: ___________________

 

4.Number of Warrants for which Global Warrant shall be issued: __________________

 

5.Number of Warrants in name of Holder in form of Warrant Certificates after issuance of Global Warrant, if any: ___________

 

6.Global Warrant shall be delivered to the following address:

 

______________________________

 

______________________________

 

______________________________

 

______________________________

 

The undersigned hereby acknowledges and agrees that, in connection with this Global Warrant Exchange and the issuance of the Global Warrant, the Holder is deemed to have surrendered the number of Warrants in form of Warrant Certificates in the name of the Holder equal to the number of Warrants evidenced by the Global Warrant.

 

[SIGNATURE OF HOLDER]

 

Name of Investing Entity: ____________________________________________________

 

Signature of Authorized Signatory of Investing Entity: ______________________________

 

Name of Authorized Signatory: ________________________________________________

 

Title of Authorized Signatory: _________________________________________________

 

Date: _______________________________________________________________

 

 

 

 17 

 

 

Exhibit 5

 

Warrant Agent Fee Schedule

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 18 

 

EX-10.27 7 auddia_ex1027.htm FORM OF LOCK-UP AGREEMENT

Exhibit 10.27

 

LOCK-UP AGREEMENT

 

March ___, 2023

 

Ladenburg Thalmann & Co. Inc.

640 Fifth Avenue, 4th Floor

New York, New York 10019

acting as representative to the several underwriters:

 

Re:Underwriting Agreement, dated as of March ___, 2023 (the “Underwriting Agreement”), between Auddia Inc. (the “Company”) and Ladenburg Thalmann & Co. Inc., acting as representative to the several underwriters (the “Representative”)

 

Ladies and Gentlemen:

 

Defined terms not otherwise defined in this letter agreement (the “Letter Agreement”) shall have the meanings set forth in the Underwriting Agreement. Pursuant to Section 2.3 of the Underwriting Agreement and in satisfaction of a condition of the Company’s obligations under the Underwriting Agreement, the undersigned irrevocably agrees with the Company that, from the date hereof until 90 days after the Closing Date (such period, the “Restriction Period”), the undersigned will not offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the undersigned or any Affiliate of the undersigned or any person in privity with the undersigned or any Affiliate of the undersigned), directly or indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with respect to, any shares of Common Stock of the Company or securities convertible, exchangeable or exercisable into, shares of Common Stock of the Company beneficially owned, held or hereafter acquired by the undersigned (the “Securities”) or make any demand for or exercise any right or cause to be filed a registration, including any amendments thereto, with respect to the registration of any shares of Common Stock or Common Stock Equivalents or publicly disclose the intention to do any of the foregoing. Beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act. The undersigned acknowledges that the Company shall provide written notice to the transfer agent of the Company to inform them of the Restriction Period, which written notice shall include notification by email. In order to enforce this covenant, the Company shall impose irrevocable stop-transfer instructions preventing the transfer agent of the Company from effecting any actions in violation of this Letter Agreement.

 

Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer the Securities provided that (1) the Company receives a signed lock-up letter agreement (in the form of this Letter Agreement) for the balance of the Restriction Period from each donee, trustee, distributee, or transferee, as the case may be, prior to such transfer (2) any such transfer shall not involve a disposition for value, (3) such transfer is not required to be reported with the Securities and Exchange Commission in accordance with the Exchange Act and no report of such transfer shall be made voluntarily, and (4) neither the undersigned nor any donee, trustee, distributee or transferee, as the case may be, otherwise voluntarily effects any public filing or report regarding such transfers, with respect to transfer:

  

  i) as a bona fide gift or gifts;

 

  ii) to any immediate family member or to any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned (for purposes of this Letter Agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more remote than first cousin);

 

  iii) to any corporation, partnership, limited liability company, or other business entity all of the equity holders of which consist of the undersigned and/or the immediate family of the undersigned;

 

  iv) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (a) to another corporation, partnership, limited liability company, trust or other business entity that is an Affiliate of the undersigned or (b) in the form of a distribution to limited partners, limited liability company members or stockholders of the undersigned;

 

  v) if the undersigned is a trust, to the beneficiary of such trust; or

 

  vi) by will, other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the undersigned.

   

 

 

 1 

 

 

In addition, notwithstanding the foregoing, this Letter Agreement shall not restrict the delivery of shares of Common Stock to the undersigned upon (i) exercise any options granted under any employee benefit plan of the Company; provided that any shares of Common Stock or Securities acquired in connection with any such exercise will be subject to the restrictions set forth in this Letter Agreement, or (ii) the exercise of warrants; provided that such shares of Common Stock delivered to the undersigned in connection with such exercise are subject to the restrictions set forth in this Letter Agreement.

 

Furthermore, the undersigned may enter into any new plan established in compliance with Rule 10b5-1 of the Exchange Act; provided that (i) such plan may only be established if no public announcement or filing with the Securities and Exchange Commission, or other applicable regulatory authority, is made in connection with the establishment of such plan during the Restriction Period and (ii) no sale of shares of Common Stock are made pursuant to such plan during the Restriction Period.

 

The undersigned acknowledges that the execution, delivery and performance of this Letter Agreement is a material inducement to the Representative to complete the transactions contemplated by the Underwriting Agreement and the Company shall be entitled to specific performance of the undersigned’s obligations hereunder. The undersigned hereby represents that the undersigned has the power and authority to execute, deliver and perform this Letter Agreement, that the undersigned has received adequate consideration therefor and that the undersigned will indirectly benefit from the closing of the transactions contemplated by the Underwriting Agreement.

 

This Letter Agreement may not be amended or otherwise modified in any respect without the written consent of each of the Company and the undersigned. This Letter Agreement shall be construed and enforced in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The undersigned hereby irrevocably submits to the exclusive jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in Manhattan, for the purposes of any suit, action or proceeding arising out of or relating to this Letter Agreement, and hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that (i) it is not personally subject to the jurisdiction of such court, (ii) the suit, action or proceeding is brought in an inconvenient forum, or (iii) the venue of the suit, action or proceeding is improper. The undersigned hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by receiving a copy thereof sent to the Company at the address in effect for notices to it under the Underwriting Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. The undersigned hereby waives any right to a trial by jury. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The undersigned agrees and understands that this Letter Agreement does not intend to create any relationship between the undersigned and the Representative and that the Representative is not entitled to cast any votes on the matters herein contemplated and that no issuance or sale of the Securities is created or intended by virtue of this Letter Agreement.

 

This Letter Agreement shall be binding on successors and assigns of the undersigned with respect to the Securities and any such successor or assign shall enter into a similar agreement for the benefit of the Representative.

 

 

*** SIGNATURE PAGE FOLLOWS***

 

 

 

 2 

 

 

 

This Letter Agreement may be executed in two or more counterparts, all of which when taken together may be considered one and the same agreement.

 

 

__________________________

Signature

__________________________

Print Name

__________________________

Position in Company, if any

 

Address for Notice:

 

__________________________

 

__________________________

 

__________________________

 

 

Number of shares of Common Stock

 

__________________________

 

Number of shares of Common Stock underlying subject to warrants, options, debentures or other convertible securities

 

 

 

By signing below, the Company agrees to enforce the restrictions on transfer set forth in this Letter Agreement.

 

AUDDIA INC.

 

 

 

By: _________________________________

Name:

Title:

 

 

 3 

 

EX-23.1 8 auddia_ex2301.htm CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

 

 

Auddia Inc.

Boulder, Colorado

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 20, 2023, relating to our audits of the financial statements of Auddia Inc. at and for the years ended December 31, 2022 and 2021, which appear in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 23, 2023. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

 

/s/ Daszkal Bolton, LLP

 

 

Jupiter, Florida

 

March 27, 2023

EX-FILING FEES 9 auddia_ex107.htm CALCULATION OF FILING FEE TABLES

Exhibit 107

 

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

AUDDIA INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type
Security
Class
Title
Fee
Calculation
Rule
Amount
Registered
Proposed
Maximum
Offering
Price Per
Unit
Maximum
Aggregate
Offering
Price(1)(2)(3)
Fee
Rate
Amount of
Registration
Fee
Equity Common stock, par
value $0.001 per share
Rule 457(o)     $6,900,000 $110.20 per $1,000,000 $760.38
Equity Warrants to purchase
common stock
Other       $110.20 per $1,000,000  
Equity Pre-funded warrants to
purchase common stock(4)(5)
Other       $110.20 per $1,000,000  
Equity Common stock, par
value $0.001 per
share, underlying
warrants(6)
Other     $6,900,000 $110.20 per $1,000,000 $760.38
Equity Common stock, par
value $0.001 per
share, underlying pre-
funded warrants(4)(5)
Other       $110.20 per $1,000,000  
Total Offering Amounts/Net Fee Due   $13,800,000   $1,520.76(7)

 

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) of the Securities Act of 1933, as amended (the “Securities Act”). Pursuant to Rule 416, there are also being registered such indeterminable additional securities as may be issued to prevent dilution as a result of stock splits, stock dividends or similar transactions.
(2) Includes the price of additional shares of common stock and warrants to purchase shares of common stock that the underwriter has the right to purchase to cover over-allotments, if any. See the section titled “Underwriting” in this registration statement.
(3) Each unit to be sold in this offering will consist of one share of common stock (or one pre-funded warrant to purchase one share of common stock) and one warrant to purchase one share of common stock. In accordance with Rule 457(i) under the Securities Act, no separate registration fee is required with respect to the warrants or pre-funded warrants registered hereby.
(4) The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants offered and sold in the offering, and as such the proposed maximum offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants) if any, is $6,900,0000.
(5) The registrant may issue pre-funded warrants to purchase common stock in the offering. The purchase price of each pre-funded warrant will equal the price per share at which shares of common stock are being sold to the public in this offering, minus $0.0001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.0001 per share (subject to adjustment as provided for therein).
(6) Based on an assumed per share exercise price for the warrants to purchase common stock of 100% of the public offering price per unit in this offering.
(7) Fee was previously paid with the initial filing on March 23, 2023.

 

EX-101.SCH 10 auud-20230323.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 11 auud-20230323_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 12 auud-20230323_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
Mar. 23, 2023
Cover [Abstract]  
Document Type S-1/A
Amendment Flag true
Amendment Description various edits
Entity Registrant Name Auddia Inc.
Entity Central Index Key 0001554818
Entity Tax Identification Number 45-4257218
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2100 Central Ave.
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Boulder
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80301
City Area Code (303)
Local Phone Number 219-9771
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
XML 14 auddia_s1-a1_htm.xml IDEA: XBRL DOCUMENT 0001554818 2023-03-23 2023-03-23 iso4217:USD shares iso4217:USD shares 0001554818 true various edits S-1/A Auddia Inc. DE 45-4257218 2100 Central Ave. Suite 200 Boulder CO 80301 (303) 219-9771 Non-accelerated Filer true true false EXCEL 15 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 16 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 18 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://auddia.com/role/Cover Cover Cover 1 false false All Reports Book All Reports auddia_s1-a1.htm auddia_ex0101.htm auddia_ex0403.htm auddia_ex0404.htm auddia_ex0501.htm auddia_ex1010.htm auddia_ex1027.htm auddia_ex107.htm auddia_ex2301.htm auud-20230323.xsd auud-20230323_lab.xml auud-20230323_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 20 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "auddia_s1-a1.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 18 }, "contextCount": 1, "dts": { "inline": { "local": [ "auddia_s1-a1.htm" ] }, "labelLink": { "local": [ "auud-20230323_lab.xml" ] }, "presentationLink": { "local": [ "auud-20230323_pre.xml" ] }, "schema": { "local": [ "auud-20230323.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 18, "memberCustom": 0, "memberStandard": 0, "nsprefix": "AUUD", "nsuri": "http://auddia.com/20230323", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "auddia_s1-a1.htm", "contextRef": "From2023-03-23to2023-03-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://auddia.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "auddia_s1-a1.htm", "contextRef": "From2023-03-23to2023-03-23", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://auddia.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 21 0001683168-23-001819-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-001819-xbrl.zip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end